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Abstract 
 
Chagas disease and leishmaniasis cause thousands of deaths every year in the South countries. 
Those diseases are caused by the protozoa Trypanosoma cruzi and Leishmania spp., 
respectively. Both protozoa belong to the family Trypanosomatidae and have a digenetic life 
cycle. That is to say that they live between a vertebrate host and an invertebrate vector 
through which they are transmitted (sand flies (Phlebotominae) in Leishmania spp. and 
bloodsucking (Triatomine) in Trypanosoma cruzi). 
The main objective of this bachelor thesis is allowing the better understanding of Trypanosoma 
cruzi behaviour in in vitro and ex vivo cultures. As we could demonstrate that the behaviour of 
in vitro cultures of Leishmania spp. is pretty similar to Trypanosoma cruzi the understanding 
done with second will be useful for the first. In order to understand them, we have developed 
two mathematic models: a continuous model of the in vitro growth and an Individual-based 
Model of the ex vivo growth.  
The experimental work of in vivo cultures of the two protozoa has been done in the 
parasitology lab of the Department of Health Microbiology and Parasitology of the Universitat 
de Barcelona. An experimental method has been designed in order to know the growing curve 
of the epimastigotes during 20-30 days (no infective, reproductive, extracellular form, of 
Trypanosoma cruzi and Leishmania spp.) obtaining results that show a bi-lineal growth in the 
growing phase of the curve. The ex vivo experimental work with Trypanosoma cruzi has been 
done in the School of Pharmacy of the Ouro Preto Federal University, Brazil. Information from 
an experimental method was taken to measure the number of infected eukaryotic cells out of 
the number of counted cells of the culture and the number of amastigotes (no infective, 
reproductive, intracellular form) in the infected cells for 72 hours. At last, in this case, the 
number of infected cells at 72 hours is maximum and the amastigotes number is maximum at 
48 hours. 
From the in vitro results we have developed a continuous model where we can mathematically 
demonstrate the bi-lineal growth of the cultures and that there is a growing limitation due to 
the diffusion, or the lack of diffusion, of oxygen in the medium. Likewise, we think about a 
molecule secreted to the medium that inhibits the growing of the protozoa population in order 
to control it and facilitate the co-existence between the guest and the parasite. From the ex 
vivo results we have developed an Individual-based Model that allows us to hypothesize two 
facts. Firstly, when the tripomastigotes (infective, no reproductive, extracellular form) of 
Trypanosoma cruzi infect the eukaryotic cells, there may be a change in the membrane 
composition that does not allow the other trypomastigotes to penetrate. Secondly, the 
complete growing cycle of the amastigotes may be larger than 72h, if not we ought to observe 
oscillations in their 72 hours behaviour. 
In order to keep progressing in the understanding of these diseases, it is necessary to keep 
working with both models, as well as start working with in vivo models, since they are further 
similar at the protozoa’s behaviour in humans. 
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Resum 
 
La malaltia del Chagas i la leishmaniasis causen milers de morts anualment en els  països del 
Sud. Aquestes malalties estan causades pels protozous Trypanosoma cruzi i Leishmania spp., 
respectivament. Ambdós protozous pertanyen a la família Trypanosomatidae i el seu cicle de 
vida és digenètic, és a dir, viuen entre un hoste vertebrat i un vector invertebrat mitjançant el 
qual es transmeten (flebòtoms (Phlebotominae) en el cas de Leishmania spp. i hemípters 
predadors (Triatomine) en el cas de Trypanosoma cruzi). 
L’objectiu principal d’aquest treball de final de grau és avançar en la comprensió del 
comportament de cultius in vitro i ex vivo del protozou Trypanosoma cruzi. Com que hem 
pogut demostrar que el seu comportament en cultius in vitro és molt semblant al de 
Leishmania spp., aquesta comprensió realitzada amb T. cruzi ens serà d’ús per a Leishmania 
spp. Per fer-ho, s’han desenvolupat dos models matemàtics: un model continu dels 
creixements in vitro i un model basat en l’individu dels creixements ex vivo. 
Els experiments in vitro amb els dos protozous s’han realitzat en el Departament de 
Microbiologia i Parasitologia Sanitàries de la Universitat de Barcelona. S’ha dissenyat un 
mètode experimental que mesura el perfil de creixement dels epimastigots durant 20-30 dies 
(forma no infectiva, reproductiva i extracel·lular tant de Trypanosoma cruzi com de Leishmania 
spp.) obtenint resultats que ens indiquen un clar comportament bilineal en la fase de 
creixement. Els experiments de creixement ex vivo amb Trypanosoma cruzi s’han realitzat a 
l’Escola de Farmàcia de la Universitat Federal de Ouro Preto (Brasil). S'ha utilitzat la informació 
d'un mètode experimental que mesura el nombre de cèl·lules eucariotes infectades en funció 
del nombre de cèl·lules contades del cultiu i el nombre d’amastigots (forma no infectiva, 
reproductiva, intracel·lular) presents en cada cèl·lula infectada durant 72 hores. En aquests cas 
s’ha observat que el nombre de cèl·lules infectades és màxim a les 72 hores i el nombre 
d’amastigots és màxim a les 48 hores. 
A partir dels resultats in vitro hem construït un model continu on hem pogut demostrar 
matemàticament el creixement bilineal dels cultius i on la limitació de creixement es deu a la 
difusió, o manca d’ella, d’oxigen en el medi. També, podem suposar que hi ha algun metabòlit 
secretat per els protozous que inhibeix el seu propi creixement controlant el creixement 
poblacional i facilitant la coexistència amb el hoste. A partir dels resultats ex vivo hem 
construït un model basat en l’individu que ens ha permès hipotetitzar dos fets. Primerament, 
quan els tripomastigots (forma infectiva, no reproductiva, extracel·lular) de Trypanosoma cruzi  
infecten a les cèl·lules eucariotes, aquestes canvien la seva composició de membrana perquè 
no puguin entrar més protozous. La segona hipòtesi és que el cicle de creixement complet dels 
amastigots dura més de 72h perquè sinó observaríem oscil·lacions en les gràfiques que 
representen el seu nombre absolut per cèl·lula infectada. 
Per seguir avançant en la comprensió d’aquestes malalties, cal seguir treballant amb ambdós 
models així com començar a treballar amb models in vivo i així aproximar-nos més al 
comportament en humans. 
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Resumen 
 
La enfermedad de Chagas i la leishmaniasis provocan miles de muertos anualmente en los 
países del Sud. Estas enfermedades son causadas por los protozoos Trypanosoma cruzi  y  
Leishmania spp., respectivamente. Ambos protozoos pertenecen a la familia 
Trypanosomatidae y su ciclo de vida es digenético, es decir, viven entre un hospedador 
vertebrado y un vector invertebrado con el que se transmiten (flebotómidos (Phlebotominae) 
para Leishmania spp. y hemípteros predadores (Triatomine) para Trypanosoma cruzi). 
El objetivo principal de este trabajo de final de grado es avanzar en la comprensión del 
comportamiento de cultivos in vitro y ex vivo del protozoo Trypanosoma cruzi. Como hemos 
podido demostrar que su comportamiento en cultivos in vitro es muy similar al de Leishmania 
spp., esta comprensión realizada con Trypanosoma cruzi nos será de uso para Leishmania spp. 
Para hacerlo, hemos desarrollado dos modelos matemáticos: un modelo continuo de los 
crecimientos in vitro y un modelo basado en el individuo de los crecimientos ex vivo. 
Los experimentos in vitro de los dos protozoos se han realizado en el Departamento de 
Microbiología y Parasitología Sanitarias de la Universitat de Barcelona. Se ha diseñado un 
método experimental que mide el perfil de crecimiento de los epimastigotes durante 20-30 
días (forma no infectiva, reproductiva y extracelular de T. cruzi y Leishmania spp.) obteniendo 
resultados que nos indican un claro comportamiento bilineal en la fase de crecimiento. Los 
experimentos de crecimiento ex vivo con Trypanosoma cruzi se han realizado en la Escuela de 
Farmacia de la Universidad Federal de Ouro Preto (Brasil). Se ha utilizado la información de un 
método experimental que mide el número de células eucariotas infectadas en función del 
número de células contadas del cultivo y el número de amastigotes (forma no infectiva, 
reproductiva, intracelular) presentes en cada célula infectada durante 72 horas. En este caso 
se ha observado que el número de células infectadas es máximo a las 72 horas y  el número de 
amastigotes es máximo a las 48 horas. 
A partir de los resultados in vitro hemos construido un modelo continuo donde hemos podido 
demostrar matemáticamente el crecimiento bilineal de los cultivos y donde la limitación de 
crecimiento se debe a la difusión, o falta de ella, de oxígeno en el medio. También, podemos 
suponer que hay algún metabolito secretado por los protozoos que inhibe su propio 
crecimiento controlando así el crecimiento poblacional y facilitando la coexistencia con el 
hospedador. A partir de los resultados ex vivo hemos construido un modelo basado en el 
individuo que nos ha permitido hipotetitzar dos hechos. Primeramente, cuando los 
tripomastigotes (forma infectiva, no reproductiva, extracelular) de Trypanosoma  cruzi infectan 
a las células eucariotas, estas cambian su composición de membrada para que no puedan 
entrar más protozoos. La segunda hipótesis es que el ciclo de crecimiento completo de los 
amastigotes dura más de 72 horas porque si no observaríamos oscilaciones en las gráficas  que 
representan su número absoluto por célula infectada. 
Para seguir avanzando en la comprensión de estas enfermedades, es necesario seguir 
trabajando con ambos modelos, así como empezar a trabajar con modelos in vitro y así 
aproximarnos más al comportamiento en humanos. 
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1. Introduction 
 
1.1 Chagas disease and Leishmaniasis 
 
1.1.1 Chagas disease 
Chagas disease, also known as American trypanosomiasis, is a potentially life-threatening 
illness caused by the protozoan parasite Trypanosoma cruzi and discovered in 1909 by the 
Brazilian physician Carlos Chagas (1879–1934).  It is found mainly in endemic areas of 21 Latin 
American countries, where it is mostly vector-borne transmitted to humans by contact with 
faeces of triatomine bugs, known as 'kissing bugs', among other names, depending on the 
geographical area (WHO, 2015). 
Chagas disease has been a scourge to humanity since antiquity and it is still a relevant social 
and economic problem in many Latin American countries. About 8 million people are 
estimated to be infected worldwide, mostly in Latin America (Aguilar-Garcia, 2010). 
It is estimated that over 10.000 people die every year from clinical manifestations of Chagas 
disease, and more than 25 million people risk acquiring the disease.  
Although Chagas disease occurs mainly in Latin America, in the past decades it has been 
increasingly detected in the United States of America, Canada, and many European and some 
Western Pacific countries. This is mainly due to population mobility between Latin America 
and the rest of the world (WHO, 2015). Figure 1 shows the distribution of Chagas disease in 
absolute numbers by 2009 (no more recentl map information has been found).  
Figure 1. Chagas disease distribution, 2009. [From The Health Coach] 
Chagas’ original report is unique in the history of medicine, in the sense that a single scientist 
described in great detail both the cycle of transmission (vector, hosts, and a novel infectious 
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organism) and the acute clinical manifestations of the first identified human case. Findings 
from paleoparasitology studies that recovered T. cruzi DNA from human mummies showed 
that Chagas disease afflicted man as early as 9000 years ago (Aguilar-Garcia, 2010). 
Chagas disease presents itself in 2 phases. The initial, acute phase lasts until about 2 months 
after infection. During the acute phase, a high number of parasites circulate in the blood but in 
most cases symptoms are absent or mild. In less than 50% of people bitten by a triatomine 
bug, characteristic first visible signs can be a skin lesion or a purplish swelling of the lids of one 
eye, and they can present fever, headache, enlarged lymph glands, pallor, muscle pain, 
difficulty in breathing, swelling and abdominal or chest pain (WHO, 2015). 
During the chronic phase, the parasites are hidden mainly inside the cardiac cells and digestive 
smooth muscle cells. At long term (20 years approximately) up to 30% of patients suffer from 
cardiac disorders and up to 10% suffer from digestive (typically enlargement of the 
oesophagus or colon), neurological or mixed alterations. In later years the infection can lead to 
sudden death or heart failure caused by progressive destruction of the cardiac tissue and its 
nervous system (WHO, 2015). 
Transmission  
Chagas disease may be transmitted to humans and to more than 150 species of domestic 
animals (eg. dogs, cats and guineapigs) and wild mammals (eg. rodents, marsupials and 
armadillos). This transmission is mainly done by bloodsucking reduviid bugs of the subfamily 
Triatominae, within three overlapping cycles: domestic, peridomestic and sylvatic (Aguilar-
Garcia, 2010) . 
Although more than 130 species of triatomine bugs have been identified, only a handful are 
competent vectors for Trypanosoma cruzi in the transmission to humans: Triatoma infestans, 
Rhodnius prolixus, and Triatoma dimidiata. The Figure 2 shows the main vector that transmits 
Chagas disease: Triatoma infestans. 
Triatomines have five nymphal stages and adults 
of both sexes, all of which can harbour and 
transmit T. cruzi. The probability that a 
triatomine is infected with T. cruzi increases in 
accordance with the number of blood meals 
taken, so that older instars and adults tend to 
have the highest infection rates.  
Chagas disease can be transmitted to humans 
also by non-vectorial mechanisms such as blood transfusion and vertically from mother to 
infant. The risk of acquisition of Chagas disease after transfusion of one unit of blood from an 
infected donor is less than 10–20% and depends on several factors (e.g., the concentration of 
parasites in the donor’s blood, the blood component transfused and sometimes the parasite 
strain). 
The transmission risk seems to be higher for transfusion of platelets than for other blood 
components. Congenital transmission occurs in 5% of pregnancies or more in chronically 
Figure 2.  Triatoma infestans. The main vector that 
transmits Chagas disease 
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infected women in some regions of Bolivia, Chile, and Paraguay, and in 1–2% or less in most 
other endemic countries. These differences might be attributable to the strain of the parasite, 
the immunological status of infected mothers, placental factors and the different 
methodologies used for detection of congenital cases.  
Transfusion-based and congenital transmissions are the main forms of infestation of humans in 
urban zones and in non-endemic countries. Transmission of infection from a chronically 
infected donor of a solid organ or bone marrow is also possible and has been well documented 
in Latin America.  
In non-endemic regions, such as the USA and Canada and many parts of Europe, a few cases of 
infection mediated by transfusion and transplantation have been documented, but the actual 
number of cases might be substantially higher because of the large number of immigrants 
from endemic areas of Latin America.  
Rarely, Chagas disease can be contracted by ingestion of food or liquid contaminated with T. 
cruzi or from accidents in laboratories that deal with live parasites. Orally transmitted Chagas 
disease is usually responsible for regional outbreaks of acute infection in areas devoid of insect 
vectors. Ingestion of contaminated food such as sugar cane juice, açaí fruit juice, or raw meat 
is generally associated with massive parasitic infestation, resulting in more severe acute clinical 
presentation and high mortality (Aguilar-Garcia, 2010) . 
Challenges and guidelines against Chagas disease from the WHO 
Currently, in order to prevent and control Chagas disease, the WHO is facing many challenges: 
− Reduce the transmission of the disease by domestic vector. 
− Maintain and consolidate advances made in disease control. 
− Revert the emergence of Chagas disease in regions previously considered to be free of the 
disease. 
− Control the persistence in regions where control had been in progress, such as the Chaco 
region of Bolivia. 
− Combat the spread of the disease mainly due to increasing population mobility between 
Latin America and the rest of the world. 
− Enhance access to diagnosis and treatment for millions of infected people. 
In order to attain the goal of eliminate Chagas disease transmission and to provide health care 
for infected or ill patients, both in endemic and non-endemic countries, WHO aims to increase 
networking at the global level and reinforce regional and national capacities, focusing on: 
− Strengthening world epidemiological surveillance and information systems. 
− Preventing transmission by blood transfusion and organ transplantation in endemic and 
non-endemic countries. 
− Promoting the identification of diagnostic tests for screening and diagnosis of infections. 
− Expanding secondary prevention of congenital transmission and case management of 
congenital and non-congenital infections. 
− Promoting consensus on adequate case management (WHO, 2015). 
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1.1.2 Leishmaniasis  
Leishmaniasis is caused by a protozoa parasite from over 20 Leishmania species and is 
transmitted to humans by the bite of infected female phlebotomine sandflies. Over 90 sandfly 
species are known to transmit Leishmania parasites (WHO, Leishmaniasis, 2015). 
The first description of the parasite responsible of the Leishmaniasis was in 1903 by Leishman, 
Donovan and Wright from visceral and cutaneous biopsies of sick people from India. Two years 
before, in 1901, Leishman identified certain organisms in smears taken from the spleen of a 
patient who had died from "dum-dum fever" (Dum Dum is an area close to Calcutta), but was 
not until then that a series of experimental infections were carried out to some volunteers 
patients who were infected to demonstrate the pathogen power of the new protozoan. 
The disease affects some of the poorest people on the planet, and it is associated with 
malnutrition, population displacement, poor housing, a weak immune system and lack of 
resources. It is estimated that there are 1’3 million new cases and 20.000 to 30.000 deaths 
annually (Ezquerra, 2001). 
 
There are three main types of leishmaniasis (in section “1.2.5 Types of Leishmaniasis and 
species of Leishmania” it is widely explained): visceral leishmaniasis, mucocutaneous 
leishmaniasis and cutaneous leishmaniasis. Figure 3 shows the geographical distribution of the 
three types. 
 
 
Figure 3. Geographical distribution of leishmaniasis. 1. Visceral leishmaniasis. 2. Mucocutaneous leishmaniasis.        
3. Cutaneous leishmaniasis due to L. tropica and L. aethiopica. 4. Cutaneous leishmaniasis due to L. major.         
(WHO, Leishmaniasis, 2015) 
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Transmission  
Leishmania parasites are transmitted through the 
bites of infected female phlebotomine sandflies 
(Figure 4). About 70 animal species, including 
humans, have been found as natural reservoir 
hosts of Leishmania parasites.  
The epidemiology of leishmaniasis depends on the 
characteristics of the parasite species and the local 
ecological characteristics of the transmission sites. 
Accordingly, there are five different areas where 
different Leishmaniasis is found: 
  
− Mediterranean basin 
In the Mediterranean basin, visceral leishmaniasis is the main form of the disease. It occurs in 
rural areas, in villages of mountainous regions and also in some periurban areas, 
where Leishmania parasites live in dogs and other animals. 
 
− South-East Asia 
In South-East Asia, visceral leishmaniasis is the main form of the disease. Transmission 
generally occurs in rural areas below 600m above sea level, with a heavy annual rainfall, with a 
mean humidity above 70%, a temperature range of 15-38 °C, abundant vegetation, subsoil 
water and alluvial soil. The disease is more common in agricultural villages where houses are 
frequently constructed with mud walls and earthen floors, and cattle and other livestock live 
close to humans. 
 
− East Africa 
In East Africa, there are frequent outbreaks of visceral leishmaniasis in the northern acacia–
balanite savanna and the southern savanna and forest areas where sandflies live around 
termite mounds. Cutaneous leishmaniasis occurs in the highlands of Ethiopia and other places 
in East Africa, where increased human–fly contact occurs in villages built on rock hills or river 
banks, the natural habitat of hyraxes. 
 
− Afro-Eurasia 
In Afro-Eurasia, cutaneous leishmaniasis is the main form of the disease. Agricultural projects 
and irrigation schemes can increase the prevalence of cutaneous leishmaniasis as people who 
have no immunity to the disease move in to work on the projects. Large outbreaks in densely 
populated cities also occur, especially during war and large-scale population migration. The 
parasites causing cutaneous leishmaniasis live mainly on humans or rodents. 
 
− Americas 
Kala-azar in the Americas is very similar to that found in the Mediterranean basin. The habit of 
keeping dogs and other domestic animals inside the house is thought to promote human 
infection. The epidemiology of cutaneous leishmaniasis in the Americas is complex, with 
Figure 4.  Lutzomyia longipalpis. Main 
leishmaniasis vector form Central and South 
America 
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variations in transmission cycles, reservoir hosts, sandfly vectors, clinical manifestations and 
response to therapy, and multiple circulating Leishmania species in the same geographical 
area. 
Strategies and work against Leishmaniasis from the WHO 
The prevention and the control of leishmaniasis require a combination of intervention 
strategies because transmission occurs in a complex biological system involving the human 
host, parasite, sandfly vector and in some cases an animal reservoir host. Key strategies 
include: 
 
− The early diagnosis and effective case management reduces the prevalence of the disease 
and prevents disabilities and death. Currently there are highly effective and safe anti-
leishmanial medicines particularly for visceral leishmaniasis and access to these medicines 
has significantly improved. 
− The vector control helps to reduce or interrupt transmission of disease by controlling 
sandflies, especially in domestic conditions. Control methods include insecticide spray, use 
of insecticide–treated nets, environmental management and personal protection. 
− An effective disease surveillance is important. An early detection and treatment of cases 
can help to reduce transmission and helps monitor the spread and burden of disease. 
− The control of reservoir hosts is complex and should be tailored to the local situation. 
− Social mobilization and strengthening partnerships (e.g., mobilization and education of the 
community with effective behavioural change, partnership and collaboration with various 
stakeholders and other vector-borne disease control programs is critical. 
 
In order to control the leishmaniasis, WHO is working on: 
 
− Supporting national leishmaniasis control programmes. 
− Raising awareness and advocacy on the global burden of leishmaniasis, and promoting 
equitable access to health services for disease prevention and case management. 
− Developing evidence-based policy guidelines, strategies and standards for leishmaniasis 
prevention and control, and monitoring their implementation. 
− Providing technical support to Member States to build sustainable, effective surveillance 
system and epidemic preparedness and response. 
− Strengthening collaboration and coordination among partners, stakeholders and other 
bodies. 
− Monitoring the global leishmaniasis situation, trends and measure progress in the disease 
control, and financing. 
− Promoting research on effective leishmaniasis control including in the areas of safe, 
effective and affordable medicines, diagnostic tools and vaccines; facilitates the 
dissemination of research findings (WHO, Leishmaniasis, 2015). 
 
  
Analysis and modelling of Trypanosomatidae family in vitro and ex vivo cultures.  1. Introduction 
 Chagas disease and Leishmaniasis     
16 
 
1.2 Biology 
1.2.1 Trypanosomatidae family 
The Trypanosomatidae family consists of seven common genera of monoflagellates parasitic in 
invertebrates (leeches and arthropods) and vertebrates (Osen, 1986). 
The morphology of this protozoa’s body may be oval and without a flagellum (amastigote 
form) or elongate and slender with a single flagellum (choanomastigote form (Crithidia), 
promastigote form (Leptomonas), opisthomastigote form (Herpetomonas), epimastigote   form 
(Blastocrithidia), trypomastigote form (Trypanosoma). 
The flagellum may extend freely from the anterior end or run along the free margin of a 
delicate wavy membrane attached to the side of the body. In some cases, the flagellum 
terminates at the anterior end of the undulating membrane and in others it extends beyond as 
a free structure. The basal portion of the flagellar complex inside the body is the axoneme, a 
nine-fibered cylinder which terminates at the centriole. The distinct, darkly staining kinetoplast 
containing DNA is located near the base of the axoneme. A reservoir consisting of an 
invagination of the cuticle surrounds the axoneme along its full length; the flagellum emerges 
through the opening. A contractile vacuole empties into the reservoir from the side. 
There are two different life cycles (Figure 5). The monogenetic cycle (1, 2, 3 and 4) and the 
digenetic cycle (5, 6 and 7). The monogenetic cycle is completed in a single invertebrate host. 
While an amastigote is common to all the cycles, the final form is different and characteristic 
of the genus. The digenetic cycle has two hosts; one is invertebrate and the other is either a 
plant or a vertebrate.  
 
Figure 5. The two different life cycles of Trypanosomatidae family. 1, 2, 3 and 4 are Trypanosomatidae genus with a 
monogenetic cycle and 5,6 and 7 are Trypanosomatidae genus with digenetic cycle. [Modified from (Osen, 1986)]. 
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There are six types of bodies based on the morphological features (Osen, 1986): amastigotes, 
promastigote, choanomastigote, opisthomastigote, epimastigote and trypomastigote. Figure 6 
shows the six distinct body types, each one representing a genus.  
 
Figure 6. The body types of the genres of Trypanosomatidae family. A is the amastigote form, B is the promastigote 
form, C is the choanomastigote form, D is the opisthomastigte form, E is the epimastigote form and F is the 
trypomastigote form. [Modified from (Osen, 1986)]. 
 
The first form (A in Figure 6) is the amastigote form, formerly the leishmanial form. It is a small 
rounded or oval body without a flagellum. It occurs as one stage in all of the life cycles and is 
representative of the genus Leishmania.  
The second one (Figure 6B) is the promastigote form. It is characteristic of the protozoa 
leptomonad and has a slender, spindle-shaped body with a free flagellum. The kinetoplast is 
near the anterior end of the body. There is no undulating membrane. This form represents the 
genus Leptomonas. 
The third form (Figure 6C) is choanomastigotes. Under this form, the organisms are small, 
flagellated bodies with broad ends, a truncated anterior and a rounded posterior. The 
flagellum emerges from the funnel-shaped reservoir. There is no undulating membrane. The 
kinetoplast is anterior and lateral to the nucleus. This somewhat aberrant form is characteristic 
of the genus Crithindia and does not appear in the life cycle of any other genus. 
The fourth form (Figure 6D) is opisthomastigote and represents the genus of Herpetomonas. 
The kinetoplast is posterior to the nucleus and the axoneme runs through almost the entire 
length of the body. There is no undulating membrane. 
The fifth form (Figure 6E) is the epimastigote form, which has the kinetoplast near the anterior 
margin of the nucleus. A short undulating membrane is present. This form represents the 
genus Blastocrithidia. 
The last form (Figure 6F) is the trypomastigote form, in which the kinetoplast is near the 
posterior end of the body and an undulating membrane runs the full length of the parasite. 
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There may or may not be a free flagellum. This form is characteristic of the genus 
Trypanosoma and does not appear in the life cycle of any other genus (Osen, 1986). 
Trypanosomatids with a digenetic cycle 
Trypanosomatids with a digenetic type of life cycle include an invertebrate as one host and a 
plant or a vertebrate as the other. Specifically, the genus Leishmania vectors are sandflies 
(Phlebotominae subgenera) and mammals as hosts. The genus Trypanosoma requires leeches 
or bloodsucking insects (Triatomines subfamily of the Reduviidae family) as the invertebrate 
hosts and vertebrates of various kinds as the alternate hosts. 
Therefore, those trypanosomatids can parasitize bugs and plants or mammals and insects. 
Those who parasite the mammals are responsible of many diseases in man and his domestic 
mammals.  The pathogenic species normally occur in tropical and semitropical regions, being 
limited by the distribution of their insect vectors. A few species that have dropped the insect 
vector from their life cycles are transmitted mechanically or by venereal contact (Osen, 1986). 
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1.2.2 Genus Trypanosoma 
Trypanosoma is one of the seven genera of the family Trypanosomatidae (Osen, 1986). This 
genus has seven subgenera: Trypanosoma theileri (Megatrypanum), Trypanosoma lewisi 
(Herpetosoma), Trypanosoma cruzi (Schizotrypanum), Trypanosoma vivax (Duttonella), 
Trypanosoma congolense (Nannomonas), Trypanosoma suis (Pycnomonas) and Trypanosoma 
brucei (Trypanozoon). 
The Trypanosoma are parasites of the blood, lymph, tissues, or cavities of all classes of 
vertebrates.  The transmission of the infective stage from one vertebrate host to another may 
take place in several ways. These can include (Osen, 1986): 
− Inoculative and contaminative means during feeding of the invertebrate vectors. 
− Mechanical transfer by vectors. 
− Transmission by venereal contact of two vertebrate hosts. 
While taking blood meals, vectors, such as leeches feeding on fish and amphibians and tsetses 
on mammals and crocodiles, inject infective trypomastigotes directly into the host. In the case 
of bugs, keds, and fleas, which defecate while feeding, the trypomastigotes are voided with 
the feces, contaminating the area around the wound which they enter.  
The stages occurring in the life cycle include four forms. They are the amastigote, 
promastigote, epimastigote and trypomastigote.  
As mentioned, in their basic life cycle there are two hosts: a vertebrate and a bloodsucking 
invertebrate. Multiplication is by binary fission and budding. When the parasite is taken into 
the alimentary canal of the invertebrate vector, it undergoes a cyclic transformation through 
one or more stages such as amastigote, promastigote, epimastigote, and finally the 
trypomastigote. The first three forms are not infective to the vertebrate host; only the 
trypomastigote is the infective stage and is known as the metatrypanosome or a metacyclic 
trypanosome. They are small trypomastigotes that develop in the anterior part of the 
alimentary canal and salivary glands in leeches and tsetses and in the posterior part of the 
digestive tract of fleas, hippoboscid flies and bloodsucking bugs. 
The trypanosomes of mammals are considered under the two major groups based on whether 
the metacyclic trypanosomes develop in the posterior or anterior stations of the vectors. 
Those two major groups are: section Stercoraria and section Salivaria (Osen, 1986). 
Section Stercoraria 
Metacyclic trypanosomes of this group develop in the rectum of the vectors and are 
discharged from the body through feces. Morphologically, the posterior end of the 
trypomastigotes from the blood is pointed and the kinetoplast is subterminal from the 
posterior end of the body. Biologically, the species of this group are characterized by the site 
of development, the manner of infection of the vertebrate host, and the place and the type of 
multiplication in the vertebrate host.  
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The metacyclic trypanosomes vectors are fleas, keds, hippoboscid flies and reduviid bugs. 
When metacyclic trypanosomes invade the vertebrate host, they do it through wounds made 
by the biting vectors, through abrasions on the skin, or via the intestinal mucosa when infected 
vectors are swallowed, entering the bloodstream from these various places of contact. The 
multiplication of the parasites in the mammalian host occurs in different forms and locations. 
Specifically Trypanosoma cruzi divides by binary fission of amastigotes inside 
reticuloendothelial cells such as macrophages in the liver, spleen, and bone marrow, and 
myocardial fibres (Osen, 1986). 
Section Salivaria 
The species of Salivaria are found primarily in tropical Africa. The distribution is predetermined 
for most species by the geographic distribution of the tsetses (Glossina spp.) which serve as 
the invertebrate vectors in whose bodies cyclic development takes place. There are different 
subgenus of the Glossina genus split into three groups of species based on a combination of 
distributional, behavioural, molecular and morphological characteristics: the savannah flies, 
the forest flies and the riverine flies (Hide, 1999). Figure 7 depicts the subgenus Glossina fusca 
fusca from the group forest flies. 
Generally, the African species of 
trypanosomes are pathogenic to humans and 
their domestic mammals, causing severe 
disease and much mortality in both, but they 
are non-pathogenic to the wild reservoir 
hosts. The salivarian species form a compact 
group that is closely related morphologically 
and biologically.  
Morphologically, these trypanosomes are 
characterized by a body that is blunt 
posteriorly and with the kinetoplast terminal or subterminal. The basic morphology of the 
trypomastigote in the blood of the mammal and the epimastigote in the midgut of the tsetse is 
similar.  
In the forms from the bloodstream, the flagellum arises from the reservoir formed by an 
inpocketing of the pellicle at a point near the posterior end of the body. The flagellum extends 
along the side of the body, being attached through an accessory membrane of lattice-like 
structure.  
Forms in the midgut, as well as in cultures, differ in some important and significant ways after 
transformation first to the epimastigotes and finally to the metacyclic trypanosomes. The 
kinetoplast is located far anterior from the end of the body. In addition to the large, highly 
convoluted anterior mitochondrion, an equally voluminous posterior one has been formed 
that extends to the hind end of the body. The presence of the posterior mitochondrion and 
dislocation of the kinetoplast may be associated with physiological requirements of the 
epimastigotes in the gut of tsetses. Upon transformation of the epimastigotes to the 
metacyclic trypanosomes, the posterior mitochondrion disappears and the kinetoplast 
Figure 7. Glossina fusca fusca 
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together with axoneme and reservoir move posteriorly to the end of the body. The nucleus 
moves back from the anterior position occupied during this stage.  
The role of the mitochondria may be associated with the physical requirements of the 
trypanosomes in their different hosts and are produced by the kinetoplast to meet these 
needs at specific times. It is postulated that the enlarged, double mitochondrion of the 
epimastigote might be associated with the greater demand of respiration in the tsetse gut, 
where the oxygen tension is low and with limited concentration of glucose. On the contrary, 
Trypomastigotes in the bloodstream with high oxygen tension and rich glucose content, do not 
require the same biochemical action and are able to function with the aid of the single, simple 
mitochondrion.  
Biologically, cyclic development takes place only in tsetses. The metacyclic trypanosomes 
develop in the proboscis, salivary glands, or intestine. Infection of the vertebrate occurs when 
the metacyclic trypanosomes are injected with the saliva form the anterior station by the flies 
while sucking blood. Multiplication in the blood of the vertebrate host is done by simple binary 
fission of the trypomastigotes, the only stage present. All the species of trypanosomes can be 
transferred directly through the mouth parts of bloodsucking insects such as tabanid and 
stomoxys flies.  
The section Salivaria is divided into three parts according to biological basis. They are the vivax 
group, the congolense group and the bruceievansi group. Each group is based on the location 
in the tsetses where cyclic development takes place. 
The trypanosomes of the vivax and congolense groups infect the vertebrates through the 
injection of the metacyclic trypanosomes with the saliva of the feeding flies (inoculative means 
of infection). A similar means of infection occurs between the leech vectors and aquatic 
vertebrates such as fish and amphibians.  
The trypanosomes of the bruceievansi group (species T. brucei, T. evansi and T. equiperdum) 
do not require an invertebrate host for their development and transfer. They are mechanically 
transmitted from one vertebrate to another mechanically by biting flies or through venereal 
contact. Therefore multiplication takes place in the bloodstream (Osen, 1986). 
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1.2.3 Trypanosoma cruzi  
Trypanosoma cruzi (Figure 8) is subgenera of the genera Trypanosoma from the family 
Trypanosomatidae (Osen, 1986). 
As it was mentioned before T. cruzi has a digenetic cycle so it has two hosts: an invertebrate 
and a vertebrate. The vertebrate common natural reservoir hosts are mainly humans but also 
include bats, opossums, raccoons, armadillos, dogs, cats, pigs and wood rats. The principal 
sites of T. cruzi in those hosts are blood, reticuloendothelial cells of the blood vessels, liver, 
spleen, lymph glands, bone marrow, the glial cells, and cardiac and skeletal muscles.  
The invertebrate hosts include a number of 
species of reduviid bugs. The common ones 
in the tropics are Panstrongylus megistus, 
Triatoma infestans and Rhodnius prolixus 
(Osen, 1986). 
The occurrence of T. cruzi in humans is 
dependent on the bites of infected bug 
vectors which acquire their infections from 
the wild reservoir mammalian hosts. In the 
tropics, the nocturnal bugs use the mud and 
thatched houses as habitats for resting 
during the days and for hunting at nights 
when they feed on the sleeping people. 
Infection occurs most commonly in rural 
and ghetto areas where poor housing provides a suitable habitat for the bugs.  
The length of T. cruzi epimastigote and trypomastigote form is approximately 20µm (both 
when is slender and broad). The posterior end of the body is pointed, as shown in the Figure 8.  
The nucleus is located near the middle of the body, and the dark kinetoplast is so large that 
produce bulges on each side of the body. The undulating membrane is weakly developed, 
having two or three convolutions, and the flagellum is always free. The diameter of 
intracellular amastigotes is between 1’5 and 4µm and their shape is oval. 
Figure 9 shows the life cycle of Trypanosoma cruzi. Upon entering the skin of the vertebrate 
host through punctures or abrasions of the skin, the metacyclic trypanosomes do not undergo 
multiplication in the blood. Instead of that they enter the reticuloendothelial cells of the liver, 
spleen, glial cells, and myocardial or the skeletal muscles and transform to amastigotes (by first 
going through the epimastigote stage). Inside the various cells the amastigotes multiply by 
binary fission, producing various individuals. When the destroyed cells rupture, the parasites 
are dumped into the blood, where they transform successively to promastigotes, 
epimastigotes and finally metacyclic trypomastigotes. Those trypomastigotes in the peripheral 
blood are infective to the arthropod vectors but they do not multiply. 
When the blood is sucked up by reduviid bugs, the trypomastigotes start the cycle of 
development in the intestine. They first transform into epimastigotes in the midgut, where the 
Figure 8. Trypanosoma cruzi (epimastigote morphological 
form) [From CDC (Centres for Disease Control and 
Prevention)] 
Analysis and modelling of Trypanosomatidae family in vitro and ex vivo cultures.  1. Introduction 
 Chagas disease and Leishmaniasis     
23 
 
initial process of multiplication by binary fission occurs. By the end of 8 to 10 days of 
multiplication, the epimastigotes change to small metacyclic trypanosomes in the rectum of 
the bugs. 
While feeding, preferably on the eyelids or lips, the bugs habitually defecate voiding feces that 
contain numerous metacyclic trypanosomes. Infection of the vertebrate host is by the 
contaminative process in which fecal matter enters the skin through punctures made by the 
biting bugs or through abrasions of the skin. 
 
 
Figure 9. The life cycle of Trypanosoma cruzi showing the three morphological forms. Epimastigote and 
tripomastigote form in the invertebrate host (red arrows) and amastigote and tripomastigote in the vertebrate host 
(blue arrows) [Modified from the CDC (Centres for Disease Control and Prevention)] 
  
Pathology 
Trypanosomiasis cruzi appears in an acute form especially in children and in a chronic stage 
mainly in adult humans. It apparently does not affect the other animals. 
Early symptoms of the acute phase appear as swelling of one, usually or both eyelids where 
the metacyclic trypanosomes have entered the tissues at the site of the bug bites. The 
inflammatory swellings at the location of the bites are known as chagomas, named after 
Chagas, who discovered the organism and the disease it causes. Later, enlargement of the 
cervical and other lymph glands, liver, and spleen occurs. Anaemia, headache and fever are 
prevalent. 
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Upon reaching the tissues, the trypanosomes enter or are engulfed by different cells, where 
they transform into amastigotes and multiply. From here, they eventually enter and multiply in 
the major lymph nodes, liver, spleen, glial cells, macrophages and myocardium, as well as 
other tissues and organs. The destruction of the cells is the final result of infection. 
The chronic form of the disease usually appears in adults and may vary at the different 
geographic areas. The damage in the chronical phase includes cardiac damage resulting in 
heart dysfunction, and enlargement of the esophagus and colon, causing impaired peristalsis. 
Additional manifestations involve parts that are affected such as nerve tissues and 
reticuloendothelial system (Osen, 1986). 
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1.2.4 Genus Leishmania 
The members of this genus appear as minute, oval amastigotes in the cells of the 
reticuloendothelial system of the skin, bone marrow, liver, spleen, and lymph nodes of 
mammals and reptiles, and as spindle-shaped promastigotes in the alimentary canal of sand 
flies, the invertebrate vector, and in cultures (Osen, 1986). 
Leishmania parasite, as it was 
mentioned before, is digenetic, so it 
performs part of its life cycle in the 
gastrointestinal tract of the 
invertebrate host in the flagellar form 
(promastigote, Figure 10) and in the 
vertebrate within mononuclear 
phagocytes, mainly macrophages in 
the amastigote form.  
When a sandfly infested engorged 
blood from a vertebrate, it inoculates 
the promastigotes present in the 
proboscis. Once the parasite is in the 
skin capillaries of the vertebrate host, 
the macrophage engulfs the 
protozoan and encompasses it in a parasitophorous vacuole trying to remove it by a cascade of 
oxygen derived metabolites and the release of lysosomal hydrolases, discharges in the 
intravacuolar space. Nevertheless, Leishmania evades all these nonspecific macrophage 
immune responses to live and multiply inside the macrophage (Osen, 1986). 
Therefore, the effectiveness of the immune response and the virulence of the protozoan are 
the determinants of the Leishmaniasis progression. If leishmanias survive, the circulating 
parasitized monocytes are engorged by other sandfly in which bowel the amastigotes are 
released and recovered the form of promastigotes. After several days, they reach their 
infectivity capacity in the vicinity of the proboscis being arranged to be inoculated. In this point 
the cycle is closed (Figure 11). 
Figure 10. Leishmania braziliensis (promastigote form) 
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Figure 11. The life cycle of Leishmania showing the three morphological forms. Amastigotes  inside the infected 
macrophages are transformed to promastigotes (red arrows) in the invertebrate host and promastigotes are 
transformed to amastigote in the vertebrate host (blue arrows)                                                                              
[Modified from the CDC (Centers for Disease Control and Prevention] 
 
It is generally accepted that Leishmania multiplication is asexual. It is performed by a 
longitudinal bipartition of promastigotes, except the metacyclic form which is a non-dividing 
form. The division starts in the nucleus, then in the basal body, then the scourge and the soma 
are shaped. The amastigotes can be divided either by bipartition or multiple divisions 
(Osen,1986).  
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1.2.5. Types of Leishmaniasis and species of Leishmania 
The genus Leishmania is the responsible of Leishmaniasis. It occurs throughout the tropical and 
subtropical regions of the world, and its geographic distribution corresponds with that of the 
sand flies responsible for transmission among the reservoir hosts and between them and man 
(WHO, Leishmaniasis, 2015). 
Leishmaniasis is caused by a protozoa parasite from over 20 Leishmania species and is 
transmitted to humans by the bite of infected female phlebotomine sandflies. The species of 
Leishmania that affect a higher number of mammals are shown in the Table 1. 
Pathology 
Over 90 sandfly species are known to transmit Leishmania parasites. There are 3 main forms of 
the disease: 
 
− Visceral leishmaniasis (also known as kala-azar) is fatal if left untreated. It is characterized 
by irregular bouts of fever, weight loss, enlargement of the spleen and liver, and anaemia. 
It is highly endemic in the Indian subcontinent and in East Africa. An estimated 200 000 to 
400 000 new cases of VL occur worldwide each year. Over 90% of new cases occur in 6 
countries: Bangladesh, Brazil, Ethiopia, India, South Sudan and Sudan. 
 
− Mucocutaneous leishmaniasis leads to partial or total destruction of mucous membranes 
of the nose, mouth and throat. Almost 90% of mucocutaneous leishmaniasis cases occur in 
the Plurinational State of Bolivia, Brazil and Peru- 
 
− Cutaneous leishmaniasis is the most common form of leishmaniasis and causes skin 
lesions, mainly ulcers, on exposed parts of the body, leaving life-long scars and serious 
disability. About 95% of CL cases occur in the Americas, the Mediterranean basin, the 
Middle East and Central Asia. Over two thirds of new CL cases occur in 6 countries: 
Afghanistan, Algeria, Brazil, Colombia, Iran (Islamic Republic of) and the Syrian Arab 
Republic. An estimated 0.7 million to 1.3 million new cases occur worldwide annually 
(WHO, Leishmaniasis, 2015). 
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Table 1. The most important species of Leishmania (affect the major number of mammals), their clinical 
manifestation, their vector and their geographical distribution 
Leishmania 
species 
Clinical 
manifestation 
Vector sand-fly species 
Disease 
distribution 
Leishmania 
infantum chagasi 
Visceral 
Lutzomyia longipalpis, 
Lutzomyia evansi 
Central and South 
America 
Leishmania 
infantum 
Visceral and 
cutaneous 
Papatasi pernicious, 
Papatasi ariasi, Papatasi 
tobbi, Papatasi neglectus 
Mediterranean 
Region 
Leishmania 
donovani 
Visceral 
Papatasi argentipes, 
Papatasi orientalis, 
Papatasi Martini 
Africa and Asia 
Leishmania tropica Cutaneous Papatasi sergenti 
Europe, Asia and 
North Africa 
Leishmania major Cutaneous 
Papatasi papatasi, 
Papatasi duboscqi, 
Papatasi salehi, Papatasi 
bergeroti 
Africa and Asia 
Leishmania 
braziliensis 
Cutaneous and 
mucocutaneous 
Lutzomyia intermedia, 
Lutzomyia  whitmani, 
Lutzomyia migonei, 
Lutzomyia welcome, 
Lutzomyia ovallesi 
South America 
Leishmania 
amazonensis 
Cutaneous and 
diffuse cutaneous 
Lutzomyia flaviscutellata 
Central and South 
America 
Leishmania 
guyanensis 
Cutaneous and 
mucocutaneous 
Lutzomyia umbratilis, 
Lutzomyia anduzei, 
Lutzomyia whitmani 
South America 
Leishmania 
mexicana 
Cutaneous and 
diffuse cutaneous 
Lutzomyia olmeca olmeca, 
Lutzomyia shannoni, 
Lutzomyia diabolica 
Central and South 
America 
Leishmania 
panamensis 
Cutaneous Lutzomyia gomezi 
Central and South 
America 
Leishmania 
peruviana 
Cutaneous 
 Lutzomyia verrucarum South America 
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1.3 Research in Trypanosomatidae family 
Research in Trypanosomatidae family of protozoa can be focused from three different scales. 
In this project, we will focus on Trypanosoma cruzi. 
Firstly, in order to understand the protozoa’s behaviour itself, its different morphological 
forms are studied with in vitro cultures with the adequate medium.  
These cultures are used to obtain and study the different evolutive forms: epimastigotes, 
tripomastigotes and amastigotes. 
 
Secondly, in order to understand the protozoa’s behaviour on mammals, there is the clinical 
research. This point of the research is focused on the monitoring of patients infected with 
Trypanosoma cruzi. The detection of parasite blood is made by in vitro culture or PCR. 
Investigation of evolution of disease can be made in mice or other mammals experimentally 
infected by Trypanosoma cruzi. 
 
Thirdly, the epidemiology studies the global behaviour and incidence of the disease. For 
example, a bachelor thesis was done in order to design a data warehouse for the global WHO 
information and surveillance system to control/eliminate Chagas disease. Also there is a lot of 
social work that cooperate with the affected population, awareness their government about 
the importance of eliminate this disease in their countries.  
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1.4 Modelling  
1.4.1 Interest of modelling 
Scientific modelling aims to find interpret and validate approximate representations of the 
systems, defined by sets of elements and concepts whose characteristics and mechanisms 
describe the relationship between objects and mathematical operations. In this context, 
computational models play a key role in expanding the horizon of cognitive science because 
they allow more large capacity calculation and visualization in exploring the systems that 
surround us (Gomes-Neves & Duarte-Teodoro, 2010).  
There are three technical uses of models in science. To explain those uses, Karplus (1983) 
provides a simple conceptual framework of systems that defines these three uses of models. 
The conceptual framework shows a single input (excitation) that arrives to a system object that 
produces a single output (response).  
One technical use of models is to understand either a real, physical system or a logic system 
such as a scientific theory. In those cases the input and the output are given and from them 
the system object is inferred. 
Another technical use is to predict the future or some state that is currently unknown. Here, 
the input and the system object are given and used to account for the observed responses so 
the output would be found. 
And finally the model made by control, that is to say, to constrain or manipulate a system to 
produce a desirable condition. In this last case, the system object and the output are designed 
as the result of an input that wants to be exactly known (Haefner, 1996). 
Classification of models 
There are four forms of models (Haefner, 1996): 
− Conceptual or Verbal: the descriptions are in a natural language.  
− Diagrammatic: made by graphical representations of the objects and relations. 
− Physical: a real, physical mock-up of a real system or object. 
− Formal: a mathematical model, usually using algebraic or differential equations. 
The formal or mathematical models can be divided according to different criteria (Haefner, 
1996). 
Firstly, we can distinguish between empirical and mechanistic models. Empirical models are a 
mathematical representation of the system or its behaviour in a purely descriptive way. 
However, mechanistic models aim to reflect the structure and the relationships of the system, 
not just a purely description. 
In many cases it is difficult to determine if a model is empirical or mechanistic, because in the 
same model we can find purely descriptive parts and mechanistic parts. 
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Secondly, we can classify models depending on the time consideration. If the time is not 
considered we talk about a static model and if is considered we talk about a dynamic model. 
Those who take into account the time, can consider time as a continuous or discrete variable. 
If the system can be solved algebraically the continuous variable will be used but if a numerical 
solution is needed, the time is treated as a discrete variable. This type of models will be 
explained more in detail in the next section. 
Thirdly, models may incorporate or not an explicit representation of space. If we have an 
explicit representation of the space we are work with spatially heterogeneous models. Those 
models can be continuous or discrete. In the continuous spatially model every point in the 
space is different, instead in the discrete spatially model the space is represented as cells or 
blocks and each spatial cell is represented as spatially homogeneous. However, if we do not 
have explicit representation of space we work with spatially homogeneous models. 
Finally, the model can allow or not random events. If the model allows them we are working 
with stochastic models. But if the model does not allow random events we are working with 
deterministic models, that is to say that all the input parameters are known (Haefner, 1996). 
There are two strategies to study a system. We talk about “Top-down approach” when we 
model the system globally and the results of the modelling and simulations show how the 
different elements of the system interact between them. In this strategy continuous equations 
are mostly used (Ferrer et al., 2008). 
We talk about the “Bottom-up approach” strategy when we model the behaviour of the 
different elements of the system and their interaction. Therefore the results are the behaviour 
patterns of the system globally.  
Sometimes a system must be studied from different spatial scales because the study of one 
particular scale can be inferred to superior or inferior scales. Consequently those systems 
cannot be studied just through one strategy. 
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1.4.2. Continuous models and Individual-based Models 
In this project we have used two types of models: continuous models and Individual-based 
Models –IbM- also known as Agent-based Models –AbM-). 
Continuous models are mostly equation based approaches, which are the traditional way to 
quantify the functional relations between the characteristic variables of an observed system in 
science. 
This formalism simplifies and guides the raising, development and communication of the 
models, because it provides a familiar and structured framework and restricts the complexity 
of models to a coarse or averaged representation of real systems. Therefore, it is usually quite 
easy to compare population models with experimental observations and with other models. 
The comparison is feasible even between models designed to deal with different situations or 
systems.  
Continuous models may synthesize experimental observations: being rapidly implemented, 
analysed and evaluated. They also provide criteria and indicators for assessing the quality of a 
given product and estimating the safety of a proposed process (Ferrer et al., 2009). 
The basic drawback of the continuous approach lies in that the object under study (protozoa’s 
communities) is not the natural agent that causes the observed patterns (protozoa). 
Continuous models intrinsically ignore how the collective behaviour of a population specifically 
comes after the activity and interactions of individual microbes and may overlook important 
information in situations where the discrete nature of the system is relevant. 
On the other hand there are the individual-based models defined by Grimm (1999) as 
“Simulation models that treat individuals as unique and discrete entities which have at least 
one property in addition to age that changes during the life cycle”. IbM was coined to name 
these discrete bottom-up approaches to biological communities in ecology during the 1970s. 
The term “spatially explicit IbM” refers to a model that includes a representation of the spatial 
configuration of the system to be represented. 
IbMs are discrete models that consider rules (equations) governing variables that characterise 
each individual at each time step, and the state of the whole system is statistically inferred. 
The resulting collective behaviour of systems containing a statistical number of individuals is 
studied and compared to experimental observations, or to theoretical results obtained from 
population models. In contrast, continuous models work with differential equations applied on 
the variables that represent the state of the system at a certain moment and operate with 
finite differences between states set at discrete time steps (Ferrer et al., 2008).  
 
Models based on individuals are required when dealing with systems composed of 
distinguishable entities that behave according to different rules, and which depend on the 
state of the individual and on its local environment. They are particularly useful to check the 
validity of any proposed mechanism operating at an individual level whose outcome is 
assessed by the macroscopic observation of a community as a whole: IbMs allow the gradual 
introduction of complexity at an individual level and the staggered study of its global effects. 
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Phenomena which are not evident or self-contained in the input rules of the model are 
frequently observed. They are called emergent behaviours (Ferrer et al., 2009). 
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1.4.3 Mathematical models of the Trypanosomatidae family  
There are different models existing in the Trypanosomatidae family field. The variety is wide, 
from molecular models which aim to model the interaction between the protozoans and the 
immunological system, in vitro cultures, in vivo cultures, organs, humans; to houses, 
ecosystems, region scale models and continental scale models. The equations presented in 
those models are mainly continuous equations.  
We can find molecular scale models in many pharmacological thesis or articles. An example is 
the study of Cossy et al., (2001). In this paper they analyse the acute phase of the disease 
showing the dynamic competence between the parasite population and antibodies 
populations. They parameterize the main properties of the variables that affect the parasite-
antibodies’ dynamics. Those variables are: parasites reproduction rate, antibodies creation 
rate, initial number of inoculated parasites and efficient rate of the antibodies against the 
parasites. 
For their part, Rabinovich and Rossell (1976) aim to build a model which describes the main 
characteristics of the Chagas disease transmission. This study has its focus on the possible 
channels by which Trypanosoma cruzi arrives at man. Also, they expose the 26 parameters that 
the model is composed by and the continuous equations through they are connected.   
There is a free available database on Internet called BibTri database (BIBliography 
on TRIatomines). This database has 6366 bibliographic references, all of them related to 
Chagas disease, especially to the insect vectors of the disease, the triatomines (Rabinovich, 
2013). 
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1.5 Framework  
The research group Computational Biology and Complex Systems (BIOCOM-SC, Universitat 
Politècnica de Catalunya-BarcelonaTech) has been researching in epidemiological diseases for 
years. They have worked with malaria, tuberculosis and now neglected tropical diseases.  
BIOCOM-SC aim to approach the mathematical modelling to the research on those diseases. 
To carry out this purpose, the modelling and simulation of different aspects of Chagas disease 
at different spatio-temporal scales (from in vitro cultures to epidemiological issues), a network 
with different organizations has been created.  
 
Firstly, the experimental culture research has been done with the Department of Health 
Microbiology and Parasitology of the Universitat de Barcelona under the supervision of the 
Dra. Cristina Riera and Dra. Roser Fisa.  Both doctors have an extensive experience in 
Leishmania and they are currently working in Trypanosoma cruzi and Leishmania.  
Also in this field of research, there was a collaboration with Claudia Martins Carneiro, 
parasitologist from the School of Pharmacy of the Ouro Preto Federal University, Brazil who 
provided us many valuable results of their in vitro and ex vivo cultures of Trypanosoma cruzi 
from their experimental work in the Laboratory of Clinical Research CIPHARMA of the School of 
Pharmacy. 
This bachelor thesis contains the result of the work done with the mentioned professionals. 
Until now the research has been done with in vitro and ex vivo cultures, however the 
perspectives are to continue with the clinical research and epidemiological research. 
The clinical research is going to be carried out with PROSICS (International Health Program of 
the Catalan Health Institute), headed by the physician Israel Molina. Finally, the 
epidemiological research is going to be done with the Department of Neglected Tropical 
Diseases (NTD) of the World Health Organization (WHO), leaded by Dr. Pedro Albajar. 
“Analysis and modelling of Trypanosomatidae family in vitro and ex vivo cultures. Chagas 
disease and leishmaniasis” has been made in this framework with the major purpose of pave 
the way in the research and the understanding of Chagas disease from a mathematical 
modelling point of view.  
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1.6  Objectives 
Analysis and modelling of Trypanosomatidae family in vitro and ex vivo cultures. Chagas 
disease and leishmaniasis is not a limited study that initiates and comes to an end with this 
document. This bachelor thesis is the beginning of a research line with different strategies that 
have been opened in order to explore many possibilities.  
The objectives may seem quite unfocussed, but that is due to those amounts of possibilities 
that must be kept in mind. We started studying the simplest system, the epimastigots culture, 
having the willingness to progress to more complex systems, until we understand the 
behaviour of the parasite in humans or mammals. The similar life cycle observed between 
epimastigotes and amastigotes cultures of Trypanosoma cruzi and Leishmania spp. shows the 
interest to take advantage of the methodologies developed with T. cruzi to study Leishmania. 
 
General objectives: 
Allow for the better understanding of Trypanosoma cruzi behaviour in in vitro and ex vivo 
cultures. 
Specific objectives: 
1. Figure out which factors determine the kinetics of in vitro epimastigotes cultures. 
2. Describe mathematically the behaviour of in vitro epimastigotes cultures. 
3. Develop a continuous model of in vitro epimastigotes cultures. 
4. Develop an image analysis technique in order to subsequently develop an Individual-based 
Model that will take into account the morphologic characteristics and changes of the 
epimastigots.  
 
5. Develop an initial Individual-based Model of ex vivo amastigotes culture of Trypanosoma 
cruzi with the goal of progress in the understanding of the culture. 
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1.7 Outline 
This bachelor thesis is divided in 5 chapters. The first chapter is the introduction and 
encompassed different information related to the diseases that are investigated in this study.  
Firstly in the first section of this chapter, Chagas disease and leishmaniasis were presented in 
rough outlines. Straightaway in the second section of the chapter, the biology of the parasites 
that produce the diseases was exposed in a decreasing taxonomy order. In Trypanosoma cruzi 
the order was: Trypanosomatidae family, Trypanosoma genus and finally Trypanosoma cruzi 
subgenus. In Leishmaniasis spp. the order was: Trypanosomatidae family, Leishmania genus 
and Leishmania spp. subgenus.  
In order to know in which scientific context the research is being done, the third section of the 
first chapter looked over the research from different scales done in the Trypanosomatidae 
family. 
As it was mentioned in the objectives section (“1.6 Objectives”), the general objective of this 
bachelor thesis is to allow the better understanding of Trypanosoma cruzi behaviour in in vitro 
and ex vivo cultures. This objective is approached from the line of research of BIOCOM-SC, that 
is to say, the modelling. For this reason, the fourth section of the first chapter was a general 
introduction to the modelling and different mathematical models of the protozoa that we are 
studying.   
The second chapter will show the experimental results of the experimental work. Those results 
are divided in two parts: In vitro culture results and ex vivo culture. A descriptive analysis of 
those results will be done in order to proceed with the mathematical modelling of the cultures.  
The third chapter presents the models. On the one hand, the in vitro culture that contains the 
epimastigotes morphology of the protozoa was tackled with continuous models. On the other 
hand, the ex vivo culture that contains the amastigotes morphology of the protozoa was 
tackled with Individual-based Modelling. 
Finally, the fourth and the fifth chapter describe the results and conclusions and the 
perspectives of the bachelor thesis, respectively.  
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2. Experimental work 
 
2.1 In vitro 
 
The experimental work that we did in vitro had the objective of seeing how different strains of 
Trypanosoma cruzi epimastigotes growth.  
2.1.1 Material and methods 
 
In the Department of Health Microbiology and Parasitology of the Universitat de Barcelona, we 
measured the growth of the epimastigote form of Trypanosoma cruzi during the period of a 
month. The strains of the Trypanosoma cruzi used are: 
− Trypanosoma cruzi strain (BCN 585) genotype Tc II de Brazil. 
− Trypanosoma cruzi strain (BCN 585) Maracay, genotype Tc I Venezuela. 
− Trypanosoma cruzi strain (BCN 590) genotype Tc I Bolivia. 
The method used to monitor the growth was: 
The epimastigotes were grown in a medium composed of LIT (Liver Infusion Tryptose) and 10% 
of FBS (Fetal Bovine Serum) in a 10 or 40mL flask (Figure 13) or an horizontal bottle (Figure 14) 
at 280C ± 1oC. 
During 30 days, inter daily, a sample of the growth of the Trypanosoma cruzi culture was taken 
in order to measure the cell concentration and to quantify this growing. 
The technique used to measure the growing curve was counting on the Fuchs-Rosenthal 
camera (Figure 15). This camera is characterized for having a large area of 16 mm2 divided in 
16 large squares, each one is 1mm2. Each large square is subdivided into 16 small squares with 
0.25 mm of edges and an area of 0.0625 mm2. 
To prepare the counting of the cells from the culture we did the following steps: 
Firstly, we diluted 100 µl with a Pasteur pipette (Figure 16) from the culture to an Eppendorf 
(Figure 17) with 1ml of formaldehyde 2% 
PBS.  
Secondly, we dampened the margin in 
order to stick the coverslip on the 
camera (Figure 12). Then we 
homogenized the mixture and finally 
with the micropipette (Figure 18) of 
100 µl we settled out on the camera a 
sample of the diluted culture. All this process was done in a laminar flow cabinet (Figure 19) to 
avoid contamination of our biological samples.  
Figure 12. Fuchs-Rosenthal camera with the coverslip 
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We counted the number of epimastigotes in a microscope (Figure 20). The counting was done 
in 16 little squares three times (in three different 16 small squares, so 3 big squares) (n1, n2, 
n3) we made the next calculation: Nº cells = n1 +  n2 +  n33 ∗ 16 ∗ 𝑘𝑘 ∗ 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 𝑓𝑓𝑓𝑓𝑓𝑓𝑑𝑑𝑑𝑑𝑓𝑓 
Where: 
• k = The conversion factor to obtain the data in ml/ large square (16 small squares) volume 
Therefore, 
𝑘𝑘 = 10000.0125 = 80.000 
• Dilution factor= it depends on the epimastigots concentration in the culture (in this case 
the dilution factor is 10). 
 
At the same time 5 µl of samples were taken and extended onto the slide (Figure 21) where 
they were fixed (with glutaraldehid 0.25%) and tinted (with Giemsa 10%) and covered with a 
coverslip fixed with a histolytic fixative DPX. 
In order to notice the evolution of the epimastigots morphology, different images were taken 
from all the slides by BMS Microscope (Figure 22) and Micrometrics SE premium program.  
Figures 13, 14, 15, 16, 17, 18, 19, 20, 21 and 22 are the materials used in the experimental 
work. 
 
 
Figure 13. Falcon 
[amex-vienna.at] 
 
 
Figure 14. Rectangular flask 
[amazon.com] 
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Figure 15. Fuchs-Rosenthal camera 
[laborchemiker.com.br] 
 
Figure 16. Pipette Pasteur 
[science-house.com] 
 
 
Figure 17. Eppendorf 
[biocompare.com] 
 
Figure 18. Micropipette 
[dutscher-scientific.co.uk] 
 
Figure 19. Laminar flow cabinet 
[laminarflows.co.uk] 
 
Figure 20. Microscope 
[seoenterprises.com] 
 
Figure 21. Slide 
[scientificdevice.com] 
 
Figure 22. BMS Microscope 
[medicalexpo.com] 
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2.1.2 Results 
Trypanosoma cruzi epimastigotes results 
The experimental results that are firstly shown are from the experimental work carried out at 
the Department of Health Microbiology and Parasitology of the Universitat de Barcelona. 
The tables with the results are appended in the Appendix A. The different growing curves are 
shown in Figures 23, 24 and 25. 
 
BCN 858 
 
 
Figure 23. Growing curve of the strain 858. Universitat 
de Barcelona 
BCN 582 
 
 
Figure 24. Growing curve of the strain 582. Universitat 
de Barcelona 
 
BCN 590 
 
 
Figure 25. Growing curve of the strain 590. Universitat 
de Barcelona 
 
 
In those firstly experiments, the epimastigots were fed with 10 mL of medium in a falcon. 
However, in the second measurement of the epimastigots, showed in Figure 26, they were 
grown in a rectangular flask (Figure 14) with 40 mL of medium and culture. This volume 
difference is discussed in the section “2.1.3 Analysis of the results”. 
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BCN 590 (2) 
 
Figure 26. Growing curve of the strain 590 (2). 
Universitat de Barcelona 
 
 
From the School of Pharmacy of the Ouro Preto Federal University of Brasil, Claudia Martins 
Carneiro provided us many valuable results of the growth of other Trypanosoma cruzi strains 
(Be- 62 and Be -78). These ones were done during the period of 20 days.  
The name of many strains is ended with 12, 6 or 3, referring to the months that the protozoa 
were inside the mice where they were previously inoculated. 
The tables with the results are appended in the Appendix A. The different growing curves are 
shown in Figures 27, 28, 29, 30, 31, 32, 33, 34, 35 and 36. 
 
Be-62 
 
Figure 27. Growing curve of the strain Be-62. Ouro 
Preto 
Be-78 
 
 
Figure 28. Growing curve of the strain Be-78. Ouro 
Preto 
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375-12-3 
 
Figure 29. Growing curve of the strain 375-12-3. Ouro 
Preto 
375-12-6 
 
Figure 30. Growing curve of the strain 375-12-6. Ouro 
Preto 
371-12-6 
 
 
Figure 31. Growing curve of the strain 371-12-6. Ouro 
Preto 
371-12-12 
 
 
Figure 32. Growing curve of the strain 371-12-12. Ouro 
Preto 
 
372-12 
 
Figure 33. Growing curve of the strain 372-12. Ouro 
Preto 
 
385-12-6 
 
Figure 34. Growing curve of the strain 385-12-6. Ouro 
Preto 
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385-12-12 
 
 
Figure 35. Growing curve of the strain 385-12-12. Ouro 
Preto 
391-12 
 
 
Figure 36. Growing curve of the strain 391-12. Ouro 
Preto 
 
Diaz (1996) in his thesis “Variabilidad intraespecífica en Trypanosoma cruzi y ensayo de nuevos 
métodos para el cribado farmacológico” did different measurements to many in vitro culture 
strains  of epimastigots.The tables with the results are appended in the Appendix A. The 
different growing curves are shown in Figures 37, 38, 39, 40, 41 and 42. 
 
Bolivia strain 
 
 
Figure 37. Growing curve of Bolivia strain. Madrid 
 
RAL strain 
 
 
Figure 38. Growing curve of RAL strain. Madrid 
 
 
GM strain 
 
 
Figure 39. Growing curve of GM strain. Madrid 
 
 
MC strain 
 
 
Figure 40. Growing curve of MC strain. Madrid 
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Y strain 
 
Figure 41. Growing curve of Y strain. Madrid 
 
Tulahuén strain 
 
Figure 42. Growing curve of Tulahuén strain. Madrid 
 
 
Leishmania results 
In the Department of Health Microbiology and Parasitology of the Universitat de Barcelona, we 
also measured the growth of Leishmania epimastigotes form for 7 days. As is shown in the 
graphics, we stopped the measurement at the growth phase (not at the final phase as we did 
with Trypanosoma cruzi). 
The tables with the results are appended in the Appendix A. The different growing curves are 
are shown in Figures 43, 44 and 45. 
Leishmania braziliensis 
 
 
Figure 43. Growing curve of Leishmania braziliensis. 
Universitat de Barcelona 
 
Leishmania major 
 
 
Figure 44. Growing curve of Leishmania major.  
Universitat de Barcelona 
 
Leishmania infantum 
 
 
Figure 45. Growing curve of Leishmania infantum. 
 Universitat de Barcelona 
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2.1.3 Analysis of the results 
 
We can observe that the growth of the different strains of Trypanosoma cruzi, Leishmania 
braziliensis and Leishmania major epimastigotes have a common pattern. The Figures 46, 47, 
48 and 49 represent those common pattern in the growing phase in different samples. 
 
 
BCN 582 strain 
 
Figure 46. Bi-linear growing phase of the strain BCN 582 
of Trypanosoma cruzi. Universitat de Barcelona 
371-12-6 strain 
 
Figure 47. Bi-linear growing phase of the strain 371-12-6 
of Trypanosoma cruzi. Ouro Preto 
 
Bolivia strain 
 
Figure 48. Bi-linear growing phase of the Bolivia strain of 
Trypanosoma cruzi. Madrid 
 
Leishmania major 
 
 
Figure 49. Bi-linear growing phase of Leishmania major. 
Universitat de Barcelona 
 
 
This general common pattern is shown in Figure 50. After a latent phase (Ferrer, Prats, & 
López, 2008) with a slow and linear growth, we can observe a quicker and also linear growth 
(growing phase). Once reached the maximum value the population decrease linearly 
(decreasing phase) till a certain value (final phase). This certain value is wide variable between 
the different samples; in some cases the culture descends to significantly low values and in 
other cases it does not reach those low quantities. In section ”3.1 Continuous model of in vitro 
culture” the reasons why this occurs are hypothesized. 
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Figure 50. Model of the growing curve of Trypanosoma cruzi epimastigotes and some Leishmania spp. 
 
The growth phase was told to be exponential by much bibliography. But it can be observed 
that there is a bi-linear growth composed by a latent phase (with its own derivative) and a 
growing phase (with its own derivative).  
The growth of the BCN 590 strain was done with two different medium conditions. If we 
observe the results of the first and the second measurement, we can notice that the amount 
of epimastigotes that the first measurement achieves is not achieved by the second 
measurement (from the last days of the first week the concentration of epimastigotes is widely 
higher in the first measurement than in the second measurement). 
 As it was previously mentioned, in the first measurement the epimastigots were fed with 10 
mL of medium (the medium was composed of LIT (Liver Infusion Tryptose) with 10% of FBS 
(Fetal Bovine Serum) in a vertical flask. 
This quantity of medium was not enough to make a correct counting of the number of 
epimastigotes correctly because each time that a sample was taken, a part of the mixture was 
removed. Therefore, the volume of the medium was been reduced and the concentration of 
the epimastigotes increased slightly constantly.  
However, in the second measurement the epimastigotes were grown in a horizontal bottle and 
feed with 40 mL of medium and culture. Consequently, the epimastigotes were not limited by 
the nutrient and the sample that was taken from the mixture was not in danger to be modified 
by the high untrue concentration of epimastigots in a very low quantity of volume. 
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2.1.4 Images analysis of Trypanosoma cruzi 
 
As it was previously mentioned, this bachelor thesis is the beginning of a research line with 
different strategies in order to explore many possibilities. Therefore, one possibility 
expounded by parasitologists is to develop an image analysis methodology. This methodology 
provides a tool to evaluate the experimental results of the in vitro cultures of Trypanosoma 
cruzi and determine the morphological changes of parasites along the growth curve. Another 
objective of such morphological determination is the use of these data to help building and 
parametrizing an Individual-based Model.  
Hence, the main objective of the analysis of the images of Trypanosoma cruzi is to develop a 
methodology to pull out the morphologic properties of the protozoa. Those properties are the 
area and the relation between its length and wideness. The two steps that must be followed to 
extract those properties are: the pre-conditioning of the image and the analysis of the image. 
Initially, we aimed to develop an automatized methodology in one phase with the program 
ImageJ. This digital image processing program is public domain and it is based on Java, 
concretely the distribution Fiji that is focused on the life sciences (MediaWiki, 2014). However 
the characteristics of our pictures did not make it possible. 
Fiji allows to detect and to analyse enough contrasted particles against the background. 
Although the program let the properties of the image be retouched, those retouches were not 
enough to obtain the images enough conditioning to be analysed. In order to reach those 
conditioning we used Adobe Photoshop CC, a better photography program. 
Therefore, the analysis of Trypanosoma cruzi images had the following two steps. A more 
detailed and wide explanation of the two steps is in Appendix B. 
Pre-conditioning 
In order to analyse the morphology of the particles with ImageJ, it is necessary to have 
contrasted and delimited shapes. Therefore, we aim to stand out the particles in front of the 
background. Moreover, it would be useful to process a model image from which all the other 
images will be automatic processed (assuming that all the images have been taken in the same 
conditions).  
The process to pre-condition the images is shown in Table 2. Figures 51 to 55 show the 
different transformations of the original images when the detailed processes are applied. 
 
Table 2. Instructions to pre-condition Trypanosoma cruzi images 
Instruction Aim of the instruction 
Open the image with Adobe Photoshop CC 
 
Start the preconditioning of the image 
Window > Actions > Registration To automatize the actions done with the 
program 
Image > Adjusts > Brightness/Contrast (Figure 
51) 
To rise up the contrast of the image 
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Image > Adjusts > Hue/Saturation 
To decolorize the background and enlighten 
the particles (Figure 52 and Figure 53) 
To have coloured particles and not coloured 
background 
Selection > Color range (Figure 54) To have black coloured particles and white 
coloured background 
Selection > Modify > Round To improve the selection 
Layer > New > Layer To avoid interference between original image 
and selection 
Tool: Paint Bucket – Color white > Click 
anywhere on the picture 
To paint the background 
Selection > Invert To select the non-painted part (i.e. particles) 
Tool: Paint Bucket – Color black > Click 
anywhere on the picture 
To paint the particles 
Selection > Deselect (Figure 55) To deselect the selection 
Stop button on action panel To finalize and save the process we just 
created 
File > Automate > Batch To condition the rest of the images 
 
 
 
Figure 51. Image of Trypanosoma cruzi culture with the contrast rose up 
 
 
Figure 52. Image of Trypanosoma cruzi culture with the saturation reduced 
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Figure 53.  Image of Trypanosoma cruzi culture with the saturation up to 100 
 
 
Figure 54.  Image of Trypanosoma cruzi culture transforming to binary 
 
 
Figure 55.  Image of Trypanosoma cruzi culture original and binary 
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Analysis of the images 
Once the pre-conditioning treatment has finished, the particles are well-contrasted and we are 
able to use ImageJ. Similarly as with Photoshop, this open-source program allows to record 
steps in a macro (a routine of steps that the program will reproduce automatically later). 
The process to analyse the images is summarized in Table 3. Figures 56 to 59 show different 
images of the processing protocol. 
 
Table 3. Instructions to analyse Trypanosoma cruzi images 
Instruction Aim of the instruction 
Open a conditioned image on ImageJ Start the analysis process 
Plugins > Macros > Record To start recording our instructions 
Analyze > Set scale (Figure 56) To define metric system units in the image 
(not pixels) 
Processes > Binary > Make binary To convert the image to binary mode 
Processes > Binary > Close To enclose all the particle area 
Processes > Binary > Fill holes To fill possible empty zones inside the 
particle 
Analyze > Set measurements (Figure 57) To select the measurements we want from 
the particles 
Analyse > Analyse particles  To obtain the desired measurements 
Image > Overlay > Labels (Figure 58) To change the color font of the numbers 
Macro window > Cerate button > File > Save 
(Figure 59) 
To save the macro, the list of instructions 
 
 
Figure 56. Scales of the images 
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Figure 57. Different measurements to analyse the images 
 
 
Figure 58.  Image of Trypanosoma cruzi culture with the measurements 
 
 
Figure 59. Macro of the process to analyse the images 
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2.2 Ex vivo 
 
The experimental work done with Trypanosoma cruzi in ex vivo conditions was carried out in 
the School of Pharmacy of the Ouro Preto Federal University of Brazil by Claudia Martins 
Carneiro. 
 
2.2.1 Material and methods 
 
24 mice with 30 days were inoculated with 5×103 blood tripomastigotes forms of Be-78 strain. 
They were cared for 12 months after the infection with feed and water. At 3, 6 and 12 months 
a blood sample of the orbital plexus was extracted from them. Then 200 µl of blood were sown 
in a sterile environment in a 15mL falcon (Figure 60) with LIT medium (Liver Infusion Tryptose) 
with 10% of FBS (Fetal bovine serum). This new culture was kept in a heater (Figure 61) at 28oC 
± 10C to measure it after 30, 60 and 90 days. 
From all those cultures, the one’s which had infected blood were chosen and transferred into 
LIT medium with 10% FBS and also 28oC ± 1oC. Those last samples were subdued to a growth 
profile and the ones which present a good profile incubated with Grace medium (specific 
medium to grow cells) to induce the metaciclogenesis.  
Then the cultures were transferred to 50mL falcons and centrifuged (Figure 62) during 30min 
at 4oC. The sediment was hung up in 10mL of 7’2 pH PBS medium. The humid mass that was 
obtained was stored in a freezer (Figure 63) at -70oC until its using.  
104 semi-confluent monolayers of Vero cells were fixed in a glass coverslip (Figure 64) and 
were inoculated with 105 metacyclic trypomastigotes from the previous cultures. Then, in 
order to remove extracellular parasites, the culture was washed with PBS and maintained at 
the 5% of CO2, 37 ªC until the time of collection of the cells (24, 48 and 72 hours after 
inoculation). 
To measure the growth profile of the amastigotes in Vero cells the method used was the same 
as in Andrade, AF. et al, (1985) after 24h, 48h and 72h of the infection. For the counting, the 
samples were fixed with methanol and dyed with Fast Panotic. 
The number of infected cells out of the total cells and the development or proliferation 
(number of amastigotes out of the number of infected cells) was examined by optical 
microscopy (Figure 65).  
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Figures 60, 61, 62, 63, 64 and 65 are the materials used in the experimental work. 
 
 
Figure 60. Falcon 
[amex-vienna.at] 
 
Figure 61. Heater 
[pblequipo2.wordpress.com] 
 
 
 
 
Figure 62. Centrifuge 
[eng.spbu.ru] 
 
 
Figure 63. Freezer  
[korean-machinery.com] 
 
 
 
 
 
Figure 64. Glass coverslip 
[livshop.com.au] 
 
 
 
Figure 65. Optical microscope 
[tedpella.com] 
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2.2.2 Results 
Trypanosoma cruzi amastigotes results 
The first measurement that Claudia Martins Carneiro did at the School of Pharmacy of the 
Ouro Preto Federal University of Brazil was number of infected cells out of the counted cells 
(100 counted cells) that their ex vivo culture have. Those results are shown in Figures 66, 67, 
68, 69, 70, 71, 72, 73, 74 and 75. They are represented in a scale from 0 to 1, so if the number 
is 0’2 it means that there were 20 infected cells out of 100 counted cells. The tables with the 
numbers are in the Appendix C.  
 
 
Be- 62 
 
 
Figure 66. Infected cells/counted cells of ex vivo culture 
of the strain Be-62. Ouro Preto 
Be-78 
 
 
Figure 67. Infected cells/counted cells of ex vivo 
culture of the strain Be-78. Ouro Preto 
 
375-12-3 
 
 
Figure 68. Infected cells/counted cells of ex vivo culture 
of the strain 375-12-3. Ouro Preto 
 
371-12-3 
 
 
Figure 69. Infected cells/counted cells of ex vivo 
culture of the strain 371-12-3. Ouro Preto 
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371-12-6 
 
 
Figure 70. Infected cells/counted cells of ex vivo culture 
of the strain 371-12-6. Ouro Preto 
372-12-6 
 
 
Figure 71. Infected cells/counted cells of ex vivo 
culture of the strain 372-12-6. Ouro Preto 
 
375-12-6 
 
 
Figure 72. Infected cells/counted cells of ex vivo culture 
of the strain 375-12-6. Ouro Preto 
 
 
385-12-6 
 
 
Figure 73. Infected cells/counted cells of ex vivo 
culture of the strain 385-12-6. Ouro Preto 
 
371-12-12 
 
 
Figure 74. Infected cells/counted cells of ex vivo culture 
of the strain 371-12-12. Ouro Preto 
 
385-12-12 
 
 
Figure 75. Infected cells/counted cells of ex vivo 
culture of the strain 385-12-12. Ouro Preto 
 
  
Analysis and modelling of Trypanosomatidae family in vitro and ex vivo cultures.  2. Experimental work 
Chagas disease and Leishmaniasis     
57 
 
The second measurement with the ex vivo culture done by Claudia Martins Carneiro at the 
School of Pharmacy of the Ouro Preto Federal University of Brazil was the number of 
amastigotes out of the number of infected cells. Those results are shown in Figures 76, 77, 78, 
79, 80, 81, 82, 83, 84, and 85. The tables with the numbers are in the Appendix C.  
 
Be- 62 
 
 
Figure 76. Number of amastigotes/infected cells of ex 
vivo culture of the strain Be-62. Ouro Preto 
Be-78 
 
 
Figure 77. Number of amastigotes/infected cells of ex 
vivo culture of the strain Be-78. Ouro Preto 
 
 
375-12-3 
 
 
Figure 78. Number of amastigotes/infected cells of ex 
vivo culture of the strain 375-12-3. Ouro Preto 
 
 
371-12-3 
 
 
Figure 79. Number of amastigotes/infected cells of ex 
vivo culture of the strain 371-12-3. Ouro Preto 
 
371-12-6 
 
 
Figure 80. Number of amastigotes/infected cells of ex 
vivo culture of the strain 371-12-6. Ouro Preto 
 
372-12-6 
 
 
Figure 81. Number of amastigotes/infected cells of ex 
vivo culture of the strain 372-12-6. Ouro Preto 
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375-12-6 
 
 
Figure 82. Number of amastigotes/infected cells of ex 
vivo culture of the strain 375-12-6. Ouro Preto 
 
385-12-6 
 
 
Figure 83. Number of amastigotes/infected cells of ex 
vivo culture of the strain 385-12-6. Ouro Preto 
 
371-12-12 
 
 
Figure 84. Number of amastigotes/infected cells of ex 
vivo culture of the strain 371-12-12. Ouro Preto 
 
385-12-12 
 
 
Figure 85. Number of amastigotes/infected cells of ex 
vivo culture of the strain 385-12-12. Ouro Preto 
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2.2.3 Analysis of the results 
 
In order to analyse and understand the behaviour of the ex vivo cultures of Claudia Martins 
Carneiro, we draw two graphics with the average of the different strains results. 
The Figure 86 depicts the results of the infected cells out of the counted cells of all the strains 
and their average. In the same way that section “2.2.2. Results”, the results are represented in 
a scale from 0 to 1. 
 
 
Figure 86. All the infected cells/counted cells of the ex vivo cultures and the average. Ouro Preto 
 
The average denotes a slightl increment of the number of infected cells out of the number of 
counted cells to the extent that the hours draw on.  
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The Figure 87 depicts the results of the number of amastigotes out of the infected cells of all 
the strains and their average. 
 
 
Figure 87. All the numbers of amastigotes/infected cells of the ex vivo cultures and the average. Ouro Preto 
 
The average denote that at 48h the number of amastigotes per infected cells is quietly higher 
than at 24h and shortly higher than at 72h.  
With all this experimental work, there are 4 parameters in ex vivo cultures that we would like 
to deduce in order to deeply understand the interaction between the protozoa and the 
eukaryotic cells: 
− The infection probability of a trypomastigote to an eukaryotic cell. 
− The transformation time from a trypomastigote to an amastigote. 
− The duplication time of an amastigote. 
− The maximum number of amastigotes that causes the differentiation of amastigote to 
trypomastigote and the lysis of the cell.  
 
Those parameters are difficult to obtain experimentally, further thinking about the real system 
we can notice that it is a complex system with a complex interaction between the protozoa 
and the cells. However from the experimental results obtained we can take out the infection 
probability.  
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The infection process was done (as is explained in “2.2.1. Materials and methods”) with 10 
trypomastigotes every 1 eukaryotic cell and as it can be observed at the Figure 82, the average 
number of infected cells out of the counted cells at 24h is 24. Therefore, the infection 
probability is: 
𝑃𝑃 inf =  𝑑𝑑𝑖𝑖
𝑑𝑑𝑡𝑡 ·  𝑑𝑑𝑐𝑐 =  24100 · 10 = 0′0024 → 0′24% 
 
This is a very low infection probability.  
Also, the average number of amastigotes that are inside the infected cells at 24h is rather low, 
1’82, this may indicate one hypothesis: if the number of amastigotes inside the cells is quite 
low, the amounts of trypomastigotes that have penetrated to the cells are also low. Hence, 
there may be a change in the membrane composition that does not allow the other 
trypomastigotes to penetrate.  
Otherwise, the complete growing cycle of the amastigotes may be larger than 72h. We 
hypothesize that because if the life cycle would be shorter than 72h we ought to observe 
oscillations in their behaviour. What is more, the duplication time of the amastigotes may be 
higher than 20h because the average numbers of amastigotes is 1’82 at 24h, 2’81 at 48h and 
2’51 at 72h.  
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3. Models development 
 
3.1 Continuous model of in vitro culture  
In order to understand the observed behaviour, we aim to develop a mathematical model 
partially empiric partially mechanistic. It will be empiric because we will impose two linear 
growths (the latent phase and the growing phase). And it will also be mechanistic because in a 
simple way we will impose the oxygen’s behaviour and its consequences against the 
population (growth and mortality). 
In many bibliography (Nepomuceno-Mejía et al., 2010), (Hernández et al., 2012) the growth of 
the epimastigotes is considered exponential. If we consider this growing behaviour, the 
differential equation that depicts it would be this: 
𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑
= 𝜇𝜇 𝑑𝑑  
𝜇𝜇: Is defined as the specific growth rate. 
𝜇𝜇 = 1
𝑑𝑑
 𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑
 
So, considering 𝜇𝜇 as a constant, we could observe an exponential growing behaviour: 
𝑑𝑑 = 𝑑𝑑0 𝑒𝑒𝜇𝜇 𝑡𝑡 
But epimastigotes do not grow as an exponential equation. This is due to the interaction 
between the cells. Therefore the specific growth rate cannot be considered a constant, 
whereas it decreases when the protozoa’ concentration increases. Mathematically this cells 
interaction is: 
𝜇𝜇 = 𝜇𝜇0
𝑑𝑑
 
Therefore the differential equation changes this way:  
𝜇𝜇0
𝑑𝑑
= 1
𝑑𝑑
 𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑
 
𝜇𝜇0 =  𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑  
Finally obtaining this linear expression:  
𝑵𝑵 = 𝑵𝑵𝟎𝟎 + 𝝁𝝁𝟎𝟎 𝒕𝒕 
 
Now, mathematically we understand that in order to explain the observed behaviour the 
model which describes the growth is a linear model. But matching up the mathematic 
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evidence with the biology of the protozoa it may be some synthesised molecule that inhibits 
the growth. 
We can similarly observe that the growth is limited (in some point the growing curve starts to 
decrease) because of some factor. From some measurements done in the Department of 
Health Microbiology and Parasitology of the Universitat de Barcelona lab (not included in this 
bachelor thesis) we have supposed that this factor is the oxygen. Graterol et al, (2012) did an 
experiment with two cultures with different height; one was three times higher than the other. 
They figured out that the growth of Trypanosoma cruzi epimastigotes is inversely proportional 
to the culture height due to the lack or excess of oxygen. 
The final phase is characterized for reaching different stable values in the samples. We 
hypothesize that those difference is due to the variations on the oxygen flux. If the diffusion of 
the oxygen between the medium and the environment is high, the final values will be higher. 
Whereas, if the diffusion between the environment and the medium is not such high, the final 
values will be lower. Besides, the completely mortality in some cultures could be explained by 
those lack of oxygen in the culture.  
Consequently, taking into account those hypotheses, we define a first model of the 
Trypanosoma cruzi growth. The mortality relies on the oxygen concentration, but pursuing   
the law of parsimony we build a simpler model which assumes that the oxygen consumption 
by the cells is constant. This is a simplification, because the oxygen consumption should be 
different if there is a growing phase cell or a decreasing phase cell and the oxygen flow should 
depend on the gradient concentration. 
Thus, in the model we will consider two variables N and O. 
𝑑𝑑: Cells number 
𝑂𝑂: Oxygen concentration 
 
To describe the behaviour between the cells and with the oxygen, we consider 5 parameters: 
 
𝑎𝑎: Linear growing velocity of the culture during the latent phase 
𝑏𝑏: Linear growing velocity of the culture 
𝑐𝑐: Mortality velocity of the cells in no oxygen conditions 
Ү: Velocity of the oxygen consumption by the cells  
𝑒𝑒: Oxygen entrance by diffusion from the external medium 
 
So the equations that describe the latent phase are: 
 
𝑑𝑑𝑑𝑑
𝑑𝑑𝑡𝑡
= 𝑎𝑎   
  
𝑑𝑑𝑑𝑑
𝑑𝑑𝑡𝑡
= −Ү 𝑑𝑑 +𝑒𝑒    when    e= 0       if  𝑂𝑂 >  𝑂𝑂𝑠𝑠 
 
As well as the equations that describe the growing phase are: 
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𝑑𝑑𝑑𝑑
𝑑𝑑𝑡𝑡
= 𝑏𝑏 − 𝑐𝑐 𝑑𝑑   when    𝑏𝑏 = 0      if   𝑂𝑂 = 0   
                                                         𝑐𝑐 = 0      if    𝑂𝑂 > 0   
                           
𝑑𝑑𝑑𝑑
𝑑𝑑𝑡𝑡
= −Ү 𝑑𝑑 + 𝑒𝑒    when    e= 0       if  𝑂𝑂 >  𝑂𝑂𝑠𝑠 
 
 𝑂𝑂𝑠𝑠 is the saturation concentration of the oxygen in the medium. It means that the diffusion of 
the oxygen will start when the oxygen concentration in the medium gets lower than the 
saturation concentration. 
Hypothesizing that the oxygen concentration limits the growth, we may expect that the 
multiplication between the epimastigotes number and the time elapsed (the integral) from the 
beginning of the latent phase to beginning of the decrease phase, should be similar in all the 
samples. Showing then, the initial concentration of the oxygen in the culture. In this way: 
 
𝑂𝑂𝑖𝑖𝑖𝑖𝑖𝑖𝑡𝑡𝑖𝑖𝑖𝑖𝑖𝑖 = 𝛼𝛼� 𝑑𝑑 ∆𝑑𝑑𝑡𝑡 𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 𝑡𝑡ℎ𝑏𝑏 𝑑𝑑𝑏𝑏𝑑𝑑𝑏𝑏𝑠𝑠𝑖𝑖𝑠𝑠𝑖𝑖𝑖𝑖𝑑𝑑 𝑝𝑝ℎ𝑖𝑖𝑠𝑠𝑏𝑏 
𝑡𝑡=0
 
 
𝛼𝛼: Fixes the relation between the product  𝑑𝑑 ∆𝑑𝑑  units and the oxygen moles consumed. 
 
The Table 2 and Figure 88 depict the result of the mentioned integral by the Ouro Preto 
strains. 
 
Table 4. Integral of the whole growing phase of Trypanosoma cruzi strains. Ouro Preto 
Samples Integral 
Be-62 3’284 
Be-78  3’672 
3 MAI 
375/12 3’451 
391/12 3’102 
6 MAI 
371/12 3’257 
372/12 3’275 
375/12 3’527 
385/12 3’108 
12 MAI 
371/12 3’386 
385/12 3’431 
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Figure 88. Integral of the whole growing phase (latent phase + growing phase) of the Ouro Preto strains 
 
Accordingly, if the abrupt fall of the protozoa’s growth is practically at the same growing 
moment in all the samples, we can deduce that this moment is due to the oxygen exhaustion. 
The hypothesis seems reasonable because the results of the integrals of the whole growing 
phase of all Ouro Preto experimental works are similar. 
The latent phase that we consider in the growing curve corresponds to the adapting metabolic 
periods or individual growing periods of the parasites.  
Therefore, with those hypotheses and the equations presented before we built a model for the 
epimastigotes growth. Figure 89 depicts the adjustment of the experimental results (circles) 
and the mathematical model (discontinuous line) of the strain 375-12-3 of Ouro Preto and the 
Table 4 shows the parameters that were used in order to build the model. This experimental-
model adjust is correct and adequate adjust. 
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Figure 89. Model and experimental results of the growing curve of the strain 375-12-3.  Ouro Preto. 
 
Table 5. Parameters and variables of Trypanosoma cruzi growing curve model 
Parameters 
dt 0’05 
𝑑𝑑0 1683333’33 
𝑂𝑂0 310000000 
Variables 
a 1300000 
b 10000000 
c 0’65 
d 1’01 
e 5000000 
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3.2 Individual-based model of ex vivo culture 
The epimastigotes form of Trypanosoma cruzi and Leishmania spp.  were modeled through a 
continuous model. However, the system composed by the trypomastigote and amastigote 
form of Trypanosoma cruzi and eukaryotic cells (described in the section “2.2.1 Materials and 
methods”) is more difficult to be modeled through continuous models. The most feasible way 
to model this dynamics is the Individual-based Model. 
In order to describe an Individual-based Model the standard protocol used is ODD (Grimm et 
al., 2006). Nevertheless, in order to simplify and facilitate the communication we describe the 
model in a more schematic form. First, we present the flow chart of the model (Figure 90). The 
meanings of the subscripts and abbreviate words are in Table 6 (in the order that they 
appeared in the flow chart). Then we explain step by step the model and finally we show the 
Netlogo program created.  
 
 
 
 
 
 
Figure 90. Flow charts of the model representing the ex vivo culture of Trypanosoma cruzi. The flow chart on the left 
is the general flow chart of the model. The flow chart on the top-right is the behaviour of each eukaryotic cell and 
the flow chart on the bottom-right is the behaviour of each Trypanosoma cruzi. 
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Table 6. Subscripts and abbreviations of the flow chart 
Subscript or abbreviation Meaning 
Ntrypincell Number of T. cruzi inside the cell 
Nmax Maximum number of T. cruzi that can be inside the cell before 
it’s break 
tint Time that T. cruzi has been inside the cell 
trepr Time needed for T. cruzi to reproduce if it is inside the cell 
t Time step 
tlatent Time needed for T. cruzi to differentiate from trypomastigote 
to amastigote 
text Time that T. cruzi is in the medium 
tdeath Time needed for T. cruzi to death if it has not infected any cell 
 
The purpose of this model is to understand how Trypanosoma cruzi behaves in an ex vivo 
culture with eukaryotic cells. We aim to comprehend processes like the infection of the 
eukaryotic cells by the protozoans, the differentiation of trypomastigotes to amastigotes and 
the reproduction of the amastigotes. 
This model is composed by two individuals: Eukaryotic cells and Trypanosoma cruzi. The 
protozoa start being trypomastigotes, so all of them are outside the cells at the beginning. 
Then they will or not infect the eukaryotic cells (based on a probability). If the trypomastigote 
does not infect an eukaryotic cell, it will be in the medium still it infects a cell or a fixed time 
passes and it dies. Otherwise, if the trypomastigote infect an eukaryotic cell, it gets 
differentiated to an amastigote being able to reproduce. After the time needed to be 
differentiated and the time needed to start reproducing, the amastigote reproduces by 
bipartition. The amastigotes will be reproducing until the number of protozoa inside the cell is 
higher than a fixed number, then the cell will lyse and the amastigotes will leave the cell and 
appear on the medium as tripomastigotes.  
Therefore, the behavior of the eukaryotic cells is: they are onto the medium without moving. If 
they are not infected they remain equal. But if they are infected by a tripomastigote, they will 
remain equal till the number of amastigotes is superior to a maximum number fixed, then the 
cell will lyse and disappear from the medium.  
Netlogo is an environment that allows the implementation of IbMs and simulation of the 
behavior of complex systems over time and space (two-dimensional or three-dimensional). It 
was designed to deal with mobile agents or individuals acting both in the same space and at 
the same time and a behavior dominated by local interactions over a period of time (Ginovart 
et al., 2011). We have implemented our model on this platform. The code of the program is in 
the Appendix D. 
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The Figure 91 shows the interface of the program when it has been initialized.  
 
Figure 91. Interface of the NetLogo program when this is just initialized 
 
 
The parameters that can be modified from the interface are: 
        
   
 
− Parameters related to T. cruzi  
 
 
       
 
  
 
 
− Parameters related to the eukaryotic cells  
Initial number of T. cruzi 
Probability of infection 
Time of the differentiation  and 
the standard deviation 
Time to reproduce  and the 
standard  deviation 
Time to die if there is no infection 
and the standard  deviation  
Initial number of cells 
Maximum diameter of the cells and the 
standard  deviation 
Distance between the cells and the 
standard  deviation 
Maximum number of amastigotes inside 
and the standard  deviation 
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The Figure 92 shows the interface of the program when the program has run for 72 time steps 
(we wanted to make it work for 72 time steps because we consider each time step as one 
hour, and 3 days of simulation was enough to compare the data of the experimental work and 
the simulation). 
 
Figure 92. Interface of the NetLogo program when is finished (after 72 time steps) 
 
The simulation pulls out different output data in numbers or graphics. Each time step the 
number data changes on the interface (so after 72 time steps we only observe one number 
data). However the graphic depicts all the variations over the time and the program also allows 
to output all the number data to an Excel sheet. 
The number data obtained is:  
− Number of infected cells 
− Percentage of infected cells 
− Number of cells that are not infected 
− Number of trypomastigotes 
− Number of amastigotes 
− Amastigotes/cell 
The graphic data obtained is: 
− Number of eukaryotic cells 
− Number of infected cells 
− Percentage of infected cells 
− Number of Trypanosoma cruzis 
− Number of amastigotes 
− Amastigotes/cell 
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We have developed and implemented an Individual-based Model. From this point on, in order 
to carry on understanding the ex vivo system presented, is necessary to parameterize the 
model. So as to do it, we should do a bibliographic work on the biologic cycle of the amastigote 
form of Trypanosoma cruzi and achieve the values of the parameters mentioned in the section 
“2.2.3 Analysis of the results” (The infection probability of a trypomastigote to an eukaryotic 
cell, the transformation time from a trypomastigote to an amastigote, the duplication time 
from an amastigote and the maximum number of amastigotes that causes the differentiation 
of amastigote to trypomastigote and the lysis of the cell). Maybe all those parameters are not 
figured out yet, so probably new specific experimental will have to be done in order to achieve 
those parameters.  
This future research that combines experimental and modelling work will be meaningful to 
turn up with physical, chemical and biological data that may be important to understand the 
behaviour of Trypanosoma cruzi in human tissues where the cells can regenerate. In this way, 
the comprehension of the protozoa’s behaviour will go one step further.   
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4. Conclusions 
 
From in vitro epimastigotes cultures of different strains of Trypanosoma cruzi and Leishmania 
spp. we have observed that there are mainly two factors that determine the kinetics of the 
culture (objective 1). Firstly, the oxygen is the limiting substance in an in vitro culture. We 
obtained the datum of the initial oxygen concentration quantity. With this known value we can 
fix the parameter of oxygen concentration in an experimental work. Therefore, other unknown 
variables can be evaluated with less uncertainty. This elimination of the initial oxygen 
concentration uncertainty could help to compare the effect of different drugs against 
Trypanosoma cruzi. Secondly, being the epimastigotes the parasite forms that live in the vector 
is reasonable to think about the existence of mechanisms to control the population and 
facilitate the co-existence between the guest and the parasite. The results suggest that there 
may be some molecule secreted to the medium that inhibits the growing of the protozoa 
population itself. If this substance were experimentally figured out, it will probably have 
pharmacological interest. 
From the mentioned deductions, we described mathematically and developed a continuous 
model of the in vitro epimastigotes cultures (objectives 2 and 3). 
We have developed a technique to process the images from in vitro cultures that will allow us 
to develop an Individual-based Model based on the epimastigotes morphology that will help to 
better understand the behaviour of Trypanosoma cruzi and other Trypanosomatidae protozoa 
(objective 4). The main objective of this future model is to correlate the morphologic changes 
of the protozoa with the different phases of the culture. 
We have developed an Individual-based Model of ex vivo amastigotes culture of Trypanosoma 
cruzi that will help to progress the understanding of the cultures behaviour (objective 5). 
With all these progresses we have achieved the general objective of this bachelor thesis, which 
was a better understanding of Trypanosoma cruzi behaviour in in vitro and ex vivo cultures. 
Once and for all, as a general conclusion of this work, it has been demonstrated the interest, 
importance and necessity of using mathematical models in order to understand Chagas 
disease and Leishmania. Accordingly, there is an obvious necessity of coordinating 
experimental work and modelling. 
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5. Perspectives 
 
The research presented in this bachelor thesis was mainly done in collaboration with the 
research group Computational Biology and Complex Systems, the Department of Health 
Microbiology and Parasitology of the Universitat de Barcelona and the School of Pharmacy of 
the Ouro Preto Federal University, Brazil. 
We have reached the specific objectives presented in section “1.6 Objectives” but in order to 
progress in the understanding of Chagas disease and Leishmaniasis and ultimately improve the 
quality life of humans and other mammals who suffer from the diseases, the research must go 
on.  
After developing a continuous model of in vitro epimastigotes culture and figured out that 
there is some metabolic substance secreted that inhibits the growing of the epimastigotes, this 
substance must be looked for. 
After developing an image analysis technique to obtain the morphologic characteristics of an in 
vitro culture, this technique should be improved and the data obtained processed for building 
an Individual-based Model of those culture.  
After developing and Individual-based Model of ex vivo amastigotes culture, we have to 
parameterize it in order to progress in the understanding of the behaviour of the protozoa in 
the cells. Once the behaviour in a cell will be known, in vivo cultures should be studied. 
Trypanosoma cruzi in those cultures have a more similar behaviour than in humans. 
In the next steps of the research, we will collaborate with a medical microbiologist team and 
physicians specialists in tropical medicine and international health. This second group is 
studying the efficacy of two drugs that now are available for Chagas disease. Those drugs are 
Benznidazol and Nifurtimox and both have unfavourable effects. Therefore, they are 
investigating methods to apply them or variations in the drugs that do not have those 
unfavourable effects.    
It is important to keep investigating and make aware the population of the Northern countries 
about those neglected diseases that affect such a big number of people because we are all 
humans, regardless of where are we from or which our economic, social or cultural situation is. 
As it is performed in the scene “the Jewish woman” from the theatre play “Terror and misery 
from the Third Reich “of Bertolt Brecht, we cannot cover our eyes to the misfortune of the 
others just because it is not ours. 
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BCN 858 
 
Table A1. Data of the growing curve of the strain BCN 858, Trypanosoma cruzi. Universitat de Barcelona 
BCN 858 
Time 
(days) 
Number of 
parasites x 106 /mL 
0 0,5 
1 1,3 
2 1,95 
5 5,4 
6 6,1 
8 11,7 
9 20 
12 39 
14 54 
16 60 
20 52 
22 50,6 
 
 
 
Figure A1. Growing curve and bi-lineal growth of the strain 858, Trypanosoma cruzi. Universitat de Barcelona 
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BCN 582 
 
Table A2. Data of the growing curve of the strain BCN 582, Trypanosoma cruzi. Universitat de Barcelona 
BCN 582 
Time 
(days) 
Number of parasites 
x 106 /mL 
0 0,5 
1 1,2 
2 3,3 
5 7,1 
6 8,5 
8 11,0 
9 23,0 
12 51,5 
14 65,5 
16 86,0 
20 57,5 
22 66,0 
 
 
 
 
Figure A2. Growing curve and bi-lineal growth of the strain 582, Trypanosoma cruzi. Universitat de Barcelona 
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BCN 590 
 
Table A3. Data of the growing curve of the strain BCN 590, Trypanosoma cruzi. Universitat de Barcelona 
BCN 590  
Time 
(days) 
Number of parasites 
x 106 /mL 
0 0,5 
1 2 
2 4 
5 17 
6 18 
8 30 
9 26 
12 36 
14 63 
16 61 
20 60 
22 59 
 
 
 
 
Figure A3. Growing curve and bi-lineal growth of the strain 590, Trypanosoma cruzi. Universitat de Barcelona 
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BCN 590 (2) 
 
Table A4. Data of the growing curve of the strain BCN 590 (2), Trypanosoma cruzi. Universitat de Barcelona 
BCN 590 (2) 
Time 
(days) 
Number of parasites x 
106 /mL 
1 1,35 
3 8,2 
6 16,2 
9 18,35 
13 28,8 
16 28 
19 27 
22 33,83 
28 30 
30 41,83 
 
 
 
 
Figure A4. Growing curve and bi-lineal growth of the strain 590 (2), Trypanosoma cruzi. Universitat de Barcelona 
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Be-62 
 
Table A5. Data of the growing curve of the strain Be-62, Trypanosoma cruzi. Ouro Preto 
Be-62 
Time (days) Number of parasites x 106 /mL Time (days) 
Number of  
parasites x 106 /mL 
1 1,67 11 21,00 
2 4,03 12 6,83 
3 6,90 13 3,33 
4 10,87 14 2,58 
5 20,33 15 3,08 
6 32,50 16 2,17 
7 46,83 17 1,17 
8 55,25 18 2,00 
9 84,33 19 2,00 
10 65,67 20 1,92 
 
 
 
 
Figure A5. Growing curve and bi-lineal growth of the strain Be-62, Trypanosoma cruzi. Ouro Preto 
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Be-78 
 
Table A6. Data of the growing curve of the strain Be-78, Trypanosoma cruzi. Ouro Preto 
Be-78 
Time (days) Number of parasites x 106/mL Time (days) 
Number of parasites 
x 106 /mL 
1 1,53 11 47,17 
2 2,47 12 50,17 
3 2,90 13 62,50 
4 5,67 14 68,83 
5 7,04 15 62,50 
6 9,80 16 40,83 
7 15,25 17 38,33 
8 19,75 18 9,67 
9 34,83 19 10,08 
10 39,33 20 7,92 
 
 
 
 
Figure A6. Growing curve and bi-lineal growth of the strain Be-78, Trypanosoma cruzi. Ouro Preto 
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375-12-3 
 
Table A7. Data of the growing curve of the strain 375-12-3, Trypanosoma cruzi. Ouro Preto 
375-12-3 
Time (days) Number of parasites x 106 /mL Time (days) 
Number of 
parasites x 106 /mL 
1 1,68 11 69,50 
2 2,58 12 71,17 
3 4,00 13 62,00 
4 7,03 14 18,17 
5 10,13 15 10,50 
6 17,45 16 7,17 
7 23,17 17 9,00 
8 38,75 18 3,42 
9 41,00 19 6,17 
10 58,67 20 6,33 
 
 
 
 
Figure A7. Growing curve and bi-lineal growth of the strain 375-12-3, Trypanosoma cruzi. Ouro Preto 
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375-12-6 
 
Table A8. Data of the growing curve of the strain 375-12-6, Trypanosoma cruzi. Ouro Preto 
375-12-6 
Time (days) Number of parasites x 106 /mL Time (days) 
Number of  
parasites x 106 /mL 
1 0,98 11 33,50 
2 1,77 12 40,67 
3 2,45 13 58,33 
4 4,57 14   
5 5,13 15 64,17 
6 6,50 16 45,83 
7 12,00 17 44,33 
8 13,63 18 28,42 
9 20,33 19 21,00 
10 30,33 20 6,50 
 
 
 
 
Figure A8. Growing curve and bi-lineal growth of the strain 375-12-6, Trypanosoma cruzi. Ouro Preto 
 
  
Analysis and modelling of Trypanosomatidae family in vitro and ex vivo cultures.  Appendix A 
Chagas disease and Leishmaniasis   
A9 
 
371-12-6 
 
Table A9. Data of the growing curve of the strain 371-12-6, Trypanosoma cruzi. Ouro Preto 
371-12-6 
Time (days) Number of parasites x 106 /mL Time (days) 
Number of 
parasites x 106 /mL 
1 1,02 11 39,50 
2 2,07 12 49,17 
3 2,35 13 57,50 
4 3,97 14 63,17 
5 7,63 15 56,67 
6 8,75 16 36,17 
7 11,08 17 21,00 
8 21,00 18 22,33 
9 23,33 19 21,25 
10 35,17 20 24,67 
 
 
 
 
Figure A9. Growing curve and bi-lineal growth of the strain 231-12-6, Trypanosoma cruzi. Ouro Preto 
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371-12-12 
 
Table A10. Data of the growing curve of the strain 371-12-12, Trypanosoma cruzi. Ouro Preto 
371-12-12 
Time (days) Number of parasites x 106 /mL Time (days) 
Number of 
parasites x 106 /mL 
1 1,12 11 24,83 
2 1,78 12 36,00 
3 2,25 13 38,17 
4 4,07 14 39,17 
5 3,67 15 40,17 
6 5,55 16 39,50 
7 9,83 17 39,83 
8 13,75 18 28,33 
9 20,50 19 32,25 
10 21,33 20 29,17 
 
 
 
 
Figure A10. Growing curve and bi-lineal growth of the strain 371-12-12, Trypanosoma cruzi. Ouro Preto 
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372-12 
 
Table A11. Data of the growing curve of the strain 372-12, Trypanosoma cruzi. Ouro Preto 
372-12 
Time (days) Number of parasites x 106 /mL Time (days) 
Number of 
parasites x 106 /mL 
1 1,38 11 37,17 
2 1,77 12 48,67 
3 3,08 13 51,67 
4 5,57 14 60,33 
5 6,17 15 58,67 
6 11,55 16 53,33 
7 15,92 17 28,67 
8 21,25 18 17,25 
9 28,50 19 23,00 
10 34,50 20 24,08 
 
 
 
 
Figure A11. Growing curve and bi-lineal growth of the strain 372-12, Trypanosoma cruzi. Ouro Preto 
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385-12-6 
 
Table A12. Data of the growing curve of the strain 385-12-6, Trypanosoma cruzi. Ouro Preto 
385-12-6 
Time (days) Number of parasites x 106 /mL Time (days) 
Number of parasites 
x 106 /mL 
1 1,63 11 32,38 
2 2,22 12 40,17 
3 3,68 13 52,33 
4 4,27 14 45,17 
5 6,38 15 41,67 
6 11,40 16 32,00 
7 13,50 17 19,83 
8 20,25 18 10,67 
9 32,25 19 2,75 
10 45,17 20 2,25 
 
 
 
 
Figure A12. Growing curve and bi-lineal growth of the strain 385-12-6, Trypanosoma cruzi. Ouro Preto 
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385-12-12 
 
Table A13. Data of the growing curve of the strain 385-12-12, Trypanosoma cruzi. Ouro Preto 
385-12-12 
Time (days) Number of parasites x 106 /mL Time (days) 
Number of 
parasites x 106 /mL 
1 1,45 11 37,17 
2 2,15 12 46,00 
3 3,15 13 48,33 
4 5,27 14 39,33 
5 7,38 15 43,83 
6 10,40 16 26,67 
7 13,67 17 29,17 
8 21,00 18 21,25 
9 25,17 19 16,25 
10 38,83 20 10,67 
 
 
 
 
Figure A13. Growing curve and bi-lineal growth of the strain 385-12-12, Trypanosoma cruzi. Ouro Preto 
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391-12 
 
Table A14. Data of the growing curve of the strain 391-12. Trypanosoma cruzi. Ouro Preto 
391-12 
Time (days) 
Number of 
parasites x 10^6 
/mL 
Time (days) 
Number of 
parasites x 
10^6 /mL 
1 1,93 11 82,67 
2 2,52 12 74,83 
3 4,25 13 79,17 
4 7,97 14 23,17 
5 11,63 15 11,00 
6 12,55 16 5,83 
7 32,75 17 4,50 
8 35,25 18 2,08 
9 50,33 19 4,50 
10 68,33 20 3,83 
 
 
 
 
Figure A14. Growing curve and bi-lineal growth of the strain 391-12, Trypanosoma cruzi. Ouro Preto 
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Bolivia strain 
 
Table A15. Data of the growing curve of the Bolivia strain. Trypanosoma cruzi. Madrid 
Bolivia strain 
Time 
(days) 
Number of  
parasites x 106 /mL 
0 0,50 
2 1,68 
4 3,81 
7 12,60 
9 21,90 
11 27,30 
14 21,95 
16 19,60 
18 20,35 
22 19,90 
 
 
 
 
Figure A15. Growing curve and bi-lineal growth of the Bolivia strain, Trypanosoma cruzi. Madrid 
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RAL strain 
 
Table A16. Data of the growing curve of the RAL strain. Trypanosoma cruzi. Madrid 
RAL strain 
Time 
(days) 
Number of  
parasites x 106 /mL 
0 0,50 
2 0,63 
4 2,70 
7 13,80 
9 15,80 
11 20,85 
14 14,90 
16 11,55 
18 9,65 
22 10,16 
 
 
 
 
Figure A16. Growing curve and bi-lineal growth of the RAL strain, Trypanosoma cruzi. Madrid 
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GM strain 
 
Table A17. Data of the growing curve of the GM strain. Trypanosoma cruzi. Madrid 
GM strain 
Time 
(days) 
Number of  
parasites x 106 /mL 
0 0,50 
2 2,03 
4 6,38 
7 14,15 
9 16,95 
11 19,45 
14 20,30 
16 22,50 
18 18,90 
22 16,85 
 
 
 
 
Figure A17. Growing curve and bi-lineal growth of the GM strain, Trypanosoma cruzi. Madrid 
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 MC strain 
 
Table A18. Data of the growing curve of the MC strain. Trypanosoma cruzi. Madrid 
MC strain 
Time 
(days) 
Number of  
parasites x 106 /mL 
0 0,50 
2 0,75 
4 3,95 
7 18,65 
9 23,90 
11 21,11 
14 16,40 
16 14,60 
18 13,30 
22 14,70 
 
 
 
 
Figure A18. Growing curve and bi-lineal growth of the MC strain, Trypanosoma cruzi. Madrid 
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Y strain 
 
Table A19. Data of the growing curve of the Y strain. Trypanosoma cruzi. Madrid 
Y strain 
Time 
(days) 
Number of  
parasites x 106 /mL 
0 0,50 
2 0,77 
4 4,10 
7 12,05 
9 22,95 
11 26,45 
14 17,65 
16 17,55 
18 14,80 
22 16,20 
 
 
 
 
Figure A19. Growing curve and bi-lineal growth of the Y strain, Trypanosoma cruzi. Madrid 
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Tulahuén strain 
 
Table A20. Data of the growing curve of the Tulahuén strain. Trypanosoma cruzi. Madrid 
Tulahuén strain 
Time 
(days) 
Number of 
 parasites x 106 /mL 
0 0,50 
2 1,84 
4 3,60 
7 11,00 
9 14,83 
11 24,38 
14 18,10 
16 16,55 
18 18,20 
22 17,90 
 
 
 
 
Figure A20. Growing curve and bi-lineal growth of the Tulahuén strain, Trypanosoma cruzi. Madrid 
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Leishmania braziliensis 
 
Table A21. Data of the growing curve of Leishmania braziliensis. Universitat de Barcelona 
Leishmania braziliensis 
Time 
(days) 
Number of  
parasites x 106 /mL 
0 0,50 
1 1,30 
2 2,70 
3 6,70 
4 19,70 
5 26,76 
7 49,80 
 
 
 
 
 
 
Figure A21. Growing curve and bi-lineal growth of the Leishmania braziliensis. Universitat de Barcelona 
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Leishmania major 
 
Table A22. Data of the growing curve of Leishmania major. Universitat de Barcelona 
Leishmania major 
Time 
(days) 
Number of  
parasites x 106 /mL 
0 0,50 
1 1,70 
2 3,60 
3 15,80 
4 55,70 
5 72,00 
7 87,75 
 
 
 
 
 
 
Figure A22. Growing curve and bi-lineal growth of the Leishmania major. Universitat de Barcelona 
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Leishmania Infantum 
 
Table A23. Data of the growing curve of Leishmania infantum. Universitat de Barcelona 
Leishmania Infantum 
Time 
(days) 
Number of  
parasites x 106 /mL 
0 0,50 
1 1,30 
2 2,40 
3 2,90 
4 1,86 
5 2,04 
7 2,70 
 
 
 
 
 
 
Figure A23. Growing curve and bi-lineal growth of the Leishmania infantum. Universitat de Barcelona 
 
 
  
 
 
 
 
 
Appendix B. Pre-conditioning and 
image analysis of Trypanosoma 
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Pre-conditioning 
In order to analyse the morphology of the protozoa with ImageJ, it is necessary to have 
contrasted and delimited shapes. Therefore, we aim to stand out the protozoa in front of the 
background. Moreover, it would be useful to process a model image from which all the other 
images will be automatic processed (assuming that all the images have been taken in the same 
conditions).  
Therefore, the better process to pre-conditioning the images is: 
Firstly, the image is opened with the Adobe Photoshop CC. We automatize the actions that the 
program does in order to be automatically reproduce the instructions: Window > Actions. And 
then use the option (registration) and start the conditioning process. 
In the preconditioning phase, our main objective is to stand out the protozoa in front of the 
background in order to differentiate the protozoa and the background. So we will increase the 
saturation of the protozoa and decrease the background saturation in order to obtain a binary 
image. 
To rise up the contrast of our image: Image > Adjusts > Brightness/Contrast (Figure B1). 
 
 
Figure B1. Image of Trypanosoma cruzi culture with the contrast rose up 
 
The background has to be decolorized and the protozoa enlighten. To realize it, the yellow’s 
saturation is reduced to zero and the magenta’s saturation is rose to the maximum:  Image > 
Adjusts > Hue/Saturation (Figure B2). 
Analysis and modelling of Trypanosomatidae family in vitro and ex vivo cultures.  Appendix B 
Chagas disease and Leishmaniasis   
 
B2 
 
 
Figure B2. Image of Trypanosoma cruzi culture with the saturation reduced 
 
Then the blue or the magenta needs to be changed in order to change the background colour. 
Hence, the arrows above the color bar are moved until the selection covers all the colors that 
were not selected before. Finally, the saturation is defined to 100 (Figure B3). 
 
Figure B3.  Image of Trypanosoma cruzi culture with the saturation up to 100 
 
Now the protozoa are high coloured and our background is not, however we want the 
protozoa with black colour and the background with white colour: Selection > Color range. The 
window showed in the Figure B4 appears. 
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Figure B4.  Image of Trypanosoma cruzi culture transforming to binary 
 
We select the grey scale on preview selection. Then we will see what is selected or not in the 
image, which is big enough to decide whether we are in the range of interest or not. Then, on 
the top menu, the sampled is selected. With Shift key pressed, different points of the 
background of our image are clicked in order to select all the background.  
The selection can be improved: Selection > Modify > Round with 1 or 2 px value. We want our 
image in black and white, therefore new layers need to be painted. For the background: Layer 
> New > Layer > Paint Bucket (white). For the protozoa: Selection > Invert> New > Layer > 
Paint Bucket (black). Finally, Selection > Deselect. The final result of this conditioning, 
compared to the original file is represented in the Figure B5. 
 
 
Figure B5.  Image of Trypanosoma cruzi culture original and binary 
 
The image is well-conditioned to be processed by ImageJ because the protozoa are 
distinguishable enough. In order to create an automated process, the button of the square on 
the actions window (stop) is pressed and the instructions named. 
To condition the rest of the files: File > Automate > Batch, selecting the instruction just 
created. 
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Analysis of the images 
Once the pre-conditioning treatment has finished, the particles are well-contrasted and we are 
able to use ImageJ. Similarly as with Photoshop, this open-source program allows to record 
steps in a macro (a routine of steps that the program will reproduce automatically later). 
Therefore, once the sample field is opened, the actions are recorded: Plugins > Macros > 
Record.  
Then the results are metric systemize between pixels and meters or micrometers. Analyze > 
Set scale (Figure B6). The menu allows choosing a known distance in the desirable units and 
the equivalence in pixels.  
 
 
Figure B6. Scales of the images 
 
Before analyzing the protozoa, ImageJ needs the photography in binary mode. As the images 
are enough contrasted, ImageJ can automatically convert the images to binary images: 
Processes > Binary > Make binary.  The command Processes > Binary > Close, closes possible 
holes on the protozoa and Processes > Binary > Fill holes fills the holes that are enclosed on 
black.  
To analyze the image ImageJ offers multiple options of measures and after automatizes the 
measurement. If the measurements that interest are a few, they can be selected: Analyze > 
Set measurements (Figure B7).  
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Figure B7. Different measurements to analyse the images 
 
Finally: Analyze > Analyze protozoa. The range of areas that are considered from the protozoa 
can be defined in order to omit fake results. The command Clear results, deletes previous 
measurement and the command In situ Show > Overlay masks marks the protozoa that are 
considered and their assigned number. 
The Figure B8 is the result of the process with the numbers and magenta colour to the selected 
protozoa: Image > Overlay > Labels. 
 
 
Figure B8.  Image of Trypanosoma cruzi culture with the measurements 
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Not all the results are valid. In this case, the information of 3, 5, 6 and 8 protozoa are accurate. 
The instructions that have been recorded (the macro) is finished and saved: Recorder > Create 
> File > Save. The macro obtained in the described process is the depicted in the Figure B9. 
 
 
Figure B9. Macro of the process to analyse the images 
 
The data obtained is copied and pasted to a program like Microsoft Excel. In order to discard 
false positives, the results have to be checked manually.  
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Table C1. Infected cells/counted cells of Trypanosoma cruzi amastigotes 
 Time (hours) Samples Average 
Be- 62 
24 0,44 0,18 0,12 0,25 
48 0,67 0,32 0,53 0,51 
72 0,46 0,38 0,34 0,39 
Be-78 
24 0,08 0,08 0,08 0,08 
48 0,44 0,33 0,18 0,32 
72 0,33 0,44 0,2 0,32 
375-12-3 
24 0,18 0,13 0,3 0,20 
48 0,42 0,62  0,52 
72 0,43 0,49 0,51 0,48 
371-12-3 
24 0,16 0,09 0,28 0,18 
48 0,53 0,52 0,56 0,54 
72 0,54 0,52 0,48 0,51 
371-12-6 
24 0,35 0,21 0,18 0,25 
48 0,5 0,35 0,42 0,42 
72 0,42 0,47 0,51 0,47 
372-12-6 
24 0,59 0,68 0,85 0,71 
48 0,48 0,71 0,73 0,64 
72 0,6 0,65 0,6 0,62 
375-12-6 
24 0,29 0,12 0,19 0,20 
48 0,24 0,22 0,34 0,27 
72 0,25 0,4 0,32 0,32 
385-12-6 
24 0,09 0,22 0,34 0,22 
48 0,27 0,25 0,3 0,27 
72 0,52 0,54 0,34 0,47 
371-12-12 
24 0,2 0,2 0,14 0,18 
48 0,35 0,32 0,38 0,35 
72 0,37 0,39 0,38 0,38 
385-12-12 
24 0,04 0,16 0,2 0,13 
48 0,16 0,23  0,20 
72 0,43 0,32 0,3 0,35 
 
  
Analysis and modelling of Trypanosomatidae family in vitro and ex vivo cultures.  Appendix C 
Chagas disease and Leishmaniasis   
 
 
C2 
 
 
Table C2. Amastigotes number / infected cells of Trypanosoma cruzi amastigotes 
 Time (hours) Samples Average 
Be- 62 
24 1,9 1,7 1,1 1,57 
48 1,5 1,4 2,4 1,77 
72 1,4 1 3,6 2,00 
Be-78 
24 2 1,5 2,6 2,03 
48 1 2,1 1,6 1,57 
72 4,8 4,8 12,7 7,43 
375-12-3 
24 1,2 1,4 1 1,20 
48 2,2 3,3 2,9 2,80 
72 2,4 3,7 1,1 2,40 
371-12-3 
24 2,6 1,1 1 1,57 
48 6,1 7,7 9,8 7,87 
72 3,4 5,2 2 3,53 
371-12-6 
24 1 1,1 1,1 1,07 
48 1,4 1 1,2 1,20 
72 1,1 1,1 1,1 1,10 
372-12-6 
24 2,7 5,1 3,1 3,63 
48 1,6 2,6 5,1 3,10 
72 1,9 1,6 1,4 1,63 
375-12-6 
24 1,7 4,3 1,1 2,37 
48 1 1,8 1,4 1,40 
72 2 2,5 1,4 1,97 
385-12-6 
24 2,2 2,5 1,2 1,97 
48 2 1 1,6 1,53 
72 1,2 1,6 1,2 1,33 
371-12-12 
24 1,1 1 1,1 1,07 
48 2,2 2,1 2,1 2,13 
72 1,3 1,5 2,6 1,80 
385-12-12 
24 1,3 1,2 2,8 1,77 
48 7,4 2,3 4,4 4,70 
72 1,2 2,4 2,2 1,93 
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;; Eukaryotic cells 
breed [cells cell] 
;; Properties: diàmeter, identifier index, amastigotes number if there is infection (= 0, no 
infection) 
cells-own [diacell classd numcell infect] 
 
;; Trypanosoma cruzi 
breed [trypanosomacruzis trypanosomacruzi] 
;; trypomastigote age, amastigote age, trypanosoma cruzi diameter, index of the cell that is 
infecting (= 0, is not infecting) 
trypanosomacruzis-own [age age1 diatrypo incell] 
 
;; Global variables 
;; number of cells, number of Trypanosoma cruzi, number of infected cells, number of 
trypanosoma cruzis infecting (amastigotes) 
globals [time ncells ntrypanosomacruzis ninfect ntrypanosomacruziinf ncdie 
ntrypanosomacruzidie 
;; Auxiliar variables 
x1 y1 x2 y2 diam1 counts inc1 move] 
 
 
;;........................START....................;; 
 
to setup 
 
  clear-all 
 
  ask patches [set pcolor one-of [119]] 
 
;;........................ INITIAL CELLS......................;; 
 
;; The forms of the cells is a circle  
   
  set-default-shape cells "circle" 
   
;; Index and counter are 0 
   
  set ncells 0 
  set counts 0 
  set ncdie 0 
  set ntrypanosomacruzidie 0 
 
;; We place the cells occupying their circular space 
;; ncellini is located on the interface 
;; The counter is arbitrary: if after n attempts the counter doesn't find free space, it let the 
placement of the cell pass 
;; The value of the counter conditions a little bit the number of cells that are inhibit 
 
  while [ (ncells < ncellini) and (counts < 100000) ] [  
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;; The position and diameter are random, the value of diacellmax is on the interface and the 
deviation is a fixed value (0.25, for the moment) 
    set x1 random-float max-pxcor  
    set y1 random-float max-pycor 
    set diam1 diacellmax * (random-normal 1 desvdiamcellini) 
     
;; The cells are created one by one taking care that they don't  overlap each other 
    ifelse all? cells [distancexy x1 y1 > (diam1 + diacell) / 2]  
    [create-cells 1 [ 
         
      set xcor x1 
      set ycor y1 
   
      set diacell diam1 
       
      set infect 0 
   
      set color 117 
       
;; The graphic size of the cells is the diameter  
      set size diam1 
   
      set ncells ncells + 1 
       
      set numcell ncells 
   
    ] 
;; If it doesn't find space, the counter add up to one more    
    ] [set counts counts + 1] 
  ] 
   
 
;;..................... INITIAL TRYPANOSOMA CRUZIS ................;; 
 
;; Their shape is a cercle and the diameter is, for the moment, fixed (diamnam on the interface) 
;; All the Trypanosoma cruzis are outside the cells 
;; To distribute the Trypanosoma cruzis, the process is the same that the cells process 
 
   
  set-default-shape trypanosomacruzis "circle" 
  set diam1 diatrypomax 
  set ntrypanosomacruzis 0 
  set counts 0 
  
   
  while [ (ntrypanosomacruzis < ntrypanosomacruziini) and (counts < 10000)] [  
   
  set x1 random-float max-pxcor  
  set y1 random-float max-pycor 
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  ifelse all? cells [distancexy x1 y1 > (diacell) / 2]  
  [create-trypanosomacruzis 1 [ 
 
      set xcor x1 
      set ycor y1 
   
      set diatrypo diam1 
   
      set color 115 
   
      set size diam1 
       
      set incell 0 
       
      set age 0 
       
      set age1 0 
   
      set ntrypanosomacruzis ntrypanosomacruzis + 1 
   
    ] 
  ]  
   
  [set counts counts + 1] 
  
  ] 
   
  set time 0 
   
  reset-ticks 
     
   
end 
 
 
 
;;...........................TIME STEPS..............................;; 
 
   
  to there-we-go 
     
  set time time + dt 
       
;;...Cells that break when they are infected by maxinfect (interface), for the moment with fixed 
noise.....;; 
 
  ask cells [ 
     
    if infect > maxinfect * (random-normal 1 desvmaxinfect)     
    [let n1 numcell 
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    set ncdie ncdie + 1 
     
    ask trypanosomacruzis [if incell = n1 [ 
   
      set color 115 
   
      set size diatrypo 
       
      set incell 0 
       
      set age 0 
       
      set age1 0 
       
 ;;     ask neighbors [ set pcolor brown ]] 
    ] 
    ] 
    die] 
    ] 
  
;;........ Movement and infection of the eukaryotic cells by the tripomastigote form of 
Trypanosoma cruzi.........;; 
 
;;....... Tripomastigotes that are infecting.......;; 
 
ask trypanosomacruzis with [incell > 0] 
[ set age1 age1 + 1 
  set age age + 1 
  let numc1 incell 
  set diam1 diatrypo 
  set move 0 
  set x1 xcor + (dist / 100) * (random-normal 0 desvdist) * dt 
  set y1 ycor + (dist / 100) * (random-normal 0 desvdist) * dt 
  ask cells with [numcell = numc1] [if distancexy x1 y1 >= diacell / 2 [set move 1 set x2 xcor set 
y2 ycor]] 
  ifelse move = 0 [set xcor x1 set ycor y1] [facexy x2 y2 fd dist / 100] 
;;  if move = 0 [set xcor x1 set ycor y1] 
   
  if (age >= tdelay * (random-normal 1 desvtdelay)) and (age1 >= trepro * (random-normal 1 
desvtrepro))   
  [set age1 0 
   ask cells with [numcell = numc1] [set infect infect + 1] 
   hatch 1 [rt random 360 fd diatrypo] 
;;   ask neighbors [ set pcolor green ] 
 
  ] 
 
  ]   
 
;;....... Tripomastigotes that are not infecting.......;; 
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  ask trypanosomacruzis with [incell = 0][ 
    set age age + 1 
    if age > tdie * (random-normal 1 desvtdie) [set ntrypanosomacruzidie ntrypanosomacruzidie 
+ 1 die] 
    set diam1 diatrypo 
    set inc1 0 
    set x1  xcor + dist * (random-normal 0 desvdist) * dt 
    set y1  ycor + dist * (random-normal 0 desvdist) * dt 
     
    set move 1  
    ask cells 
     [if distancexy x1 y1 < diacell / 2   
;;      [set move 0 if (random-float 1 < probinf) 
      [set move 0  
        if (random-float 1 < probinf) and infect = 0  
        [set inc1 numcell  
         set infect infect + 1 
         set move 1 
         set x1 xcor set y1 ycor 
        ]]] 
      
    if move = 1 [set xcor x1 set ycor y1] 
    if inc1 > 0 [set color 110 set age 0] 
;;    if inc1 > 0 [set color blue ask neighbors [ set pcolor green ]] 
    set incell inc1 
 
 
   ] 
   
     ;; 
  set ncells count cells 
  set ntrypanosomacruzis count trypanosomacruzis 
  set ntrypanosomacruziinf count trypanosomacruzis with [incell > 0]    
  set ninfect count cells with [infect > 0] 
   
  if time = 73 [stop] 
   
;;  if (ntrypanosomacruzis = 0) or (ncells = 0) [stop] 
 
if time > 168 [stop] 
   
   
  tick 
  end 
 
